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Cholesterol is a versatile molecule that determines the biophysical properties of cellular 
membranes and regulates various signalling pathways. Cholesterol has also been implicated in 
synaptic development.  In vitro studies have shown that reducing cholesterol levels can increase 
or decrease neurite outgrowth in different types of cultured neurons. However, the underlying 
mechanisms of how reduced cholesterol content of membranes affects synaptic growth have not 
been explored in detail. Cholesterol has been shown to regulate the cAMP-protein kinase A (PKA) 
pathway in non-neuronal cells. The cAMP-PKA pathway is known to be an important regulator of 
synaptic development. My primary objective was to elucidate the cellular mechanisms by which 
cholesterol regulates synaptic growth. I extracted cholesterol from Drosophila larval 
neuromuscular junctions in controls and mutants known to be involved in cAMP-PKA signalling 
and then examined the effects that this had on synaptic growth. First, I found that cholesterol is 
required for the normal synaptic growth. Second, chronic and acute cholesterol extraction reduced 
PKA activity. Next, I extracted cholesterol from mutants with elevated cAMP levels and found 
that synaptic growth was also reduced in these mutants, suggesting cholesterol may be acting 
downstream of cAMP. Furthermore, I found that cholesterol was required for activity-dependent 
synaptic growth, which is known to be regulated by cAMP-PKA signalling. Lastly, I constructed 
a vector based on domain four of the theta-toxin produced by Clostridium perfringens to serve as 
a genetically encoded cholesterol biosensor to determine the distribution of cholesterol at the 
Drosophila larval neuromuscular junction. Overall, my results suggest that cholesterol-dependent 
effects on synaptic growth may be due to changes in cAMP-PKA signalling. My findings 
demonstrate that changes in the cholesterol content of neurons can affect synaptic development, 
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 Research in neuroscience, the study of the nervous system, is fundamental to understand 
the properties of neurons and neural circuits. It involves studying the cellular and molecular 
biology, physiology, and anatomy of the nervous system, as well as learning, memory, and 
behavioural neuroscience. In the twentieth century, advances in molecular biology, 
electrophysiology, and computational technology allowed scientists to study the nervous system 
in all aspects, from structure to development to function. However, due to the high degree of 
plasticity, the formation of synapses and lifelong changes in the nervous system makes this 
dynamic system a formidable research challenge. Thus, one of the major challenges in 
neuroscience today is to explain the mechanism that directs the development of the nervous 
system.  
1.1.1 Nervous system: 
The nervous system is the central controlling, regulatory, and communicating system in 
the body. The primary nerve cells found in the nervous system are called neurons, which consist 
of a cell body that contains the nucleus and an axon that carries information away from the cell 
body. At the most basic level, the primary function of the nervous system is to transfer information. 
Unlike hormones released into circulation, the nervous system sends information to specific target 
cells through synaptic connection, thus providing a higher level of specificity at an increased 
speed.  
  Even though the nervous systems of different organisms perform the same primary 
function, the structure and complexity differ. In vertebrates, the nervous system is divided into two 
parts: the central nervous system, which consists of the brain and spinal cord, and the peripheral 




system. Invertebrate nervous systems are less complex than those of vertebrates. Because of this 
simplicity, invertebrates have served as model organisms to elucidate fundamental principles of 
neuronal system biology, such as the basis of action potentials, synaptic transmission, and axon 
pathfinding (Atwood and Karunanithi, 2002; Südhof and Rizo, 2011; Südhof; 2012; Chanaday et 
al., 2019; Russell and Bashaw, 2018).  
1.1.2 Synaptic structure and connectivity:   
In the nervous system, neurons can transmit signals to neurons or other cell types through 
specialized junctions called synapses. A synapse is an individual, specialized close contact 
between presynaptic and postsynaptic membranes, which permits neurons to pass an electrical or 
chemical signal to target the cell (Thomson, 2000; Atwood and Karunanithi, 2002). The nervous 
system consists of two different types of synapses. In electrical synapses, cell membranes are 
connected through gap junctions. This is a channel that allows the rapid transfer of signals in the 
form of electrical current to pass by causing a voltage change in the presynaptic cell to a 
postsynaptic cell (Thomson, 2000; Atwood and Karunanithi, 2002). In contrast, chemical synapses 
convert the electrical activity through voltage-gated channels into the release of chemical 
neurotransmitters. These neurotransmitters bind to the plasma membrane of postsynaptic cells. 
Additionally, synapses can consequently be classified based on the neurotransmitter they release, 
such as glutamatergic synapses that release an excitatory glutamate neurotransmitter (Davis and 
Murphey, 1994).  
Active zones are sites of neurotransmitter release in the presynaptic axon terminal or 
synaptic bouton. Active zones are composed of a dense collection of proteins called the cytomatrix 
that tether synaptic vesicles to the plasma membrane (Zenisek et al., 2000; Ahmari et al., 2000). 




Piccolo/aczonin, RIMS1 (Rab3-interacting molecule), and liprins-α (Südhof, 2012). These 
proteins serve as scaffold proteins and are components of the dense pyramid-like structures which 
function to bring synaptic vesicles into close proximity to the plasma membrane and calcium 
(Ca2+) channels (Zenisek et al., 2000, Ahmari et al., 2000). As seen in Figure 1.1, this highly 
organized complex of proteins along with the lipid membrane located at active zones are required 
for synaptic vesicle fusion and the release of neurotransmitters into the synaptic cleft (Zenisek et 
al., 2000, Ahmari et al., 2000; Atwood and Karunanithi, 2002).  
1.1.3 Mechanisms of neurotransmission: 
Neurotransmitter release can occur either by evoked neurotransmission in response to an action 
potential or through the spontaneous fusion of synaptic vesicles in the absence of action potential 
(also known as “minis”). Several studies suggest that the signal from spontaneous neurotransmitter 
release is required for maturation and stability of synaptic networks, inhibition of dendritic protein 
synthesis or even might be responsible for action potential firing in cells with high membrane 
resistance (Glitsch et al., 2008).  
In chemical synapses, neurotransmitters are synthesized in the cell body of neurons, packaged 
into vesicles, and transported to the presynaptic terminal through an axon. Vesicles are then docked 
by physically coming in contact with the plasma membrane and then primed so that they are ready-
to-fuse upon signal. Fusion is mediated by the Soluble NSF Attachment Protein Receptor 
(SNARE) complex and the calcium-binding protein, synaptotagmin (Ahmari et al., 2000; Südhof, 
2014). SNARE proteins include the synaptic vesicle protein synaptobrevin 2 (syb-2/VAMP2), 
syntaxin, and SNAP-25. As the Ca2+ ions bind to synaptotagmin, it unclamps the SNARE complex 
triggering synaptic vesicle fusion with the presynaptic terminal membrane (Südhof, 2012). Active 




presynaptic cytoplasm where vesicles are released (Wagh et al., 2006). Bruchpilot (BRP) is a vital 
element of the T-bar at Drosophila synapses. Imaging has shown that a single BRP protein reaches 
from the active zone membrane into the cytosol of boutons, thus resulting in its T shape 
morphology (Ackermann et al., 2015). Following synaptic vesicle fusion, neurotransmitters 
diffuse through the synaptic cleft and attach to receptors on the postsynaptic terminal such 
as ligand-gated ion channels and G-protein coupled receptors  (Atwood and Karunanithi, 2002; 
Südhof, 2014). These neurotransmitters binding then induces a change in the postsynaptic cell, 
thus resulting in neurotransmission.  
Binding of neurotransmitters may act to inhibit or stimulate the postsynaptic neuron. The 
stimulation of excitatory receptors upon neurotransmitter binding on the postsynaptic neuron or 
muscle causes depolarization of the postsynaptic membrane, promoting the generation of an action 
potential and allowing the message to move on. Conversely, stimulation of inhibitory receptors on 
the postsynaptic neuron or muscle causes hyperpolarisation of the postsynaptic membrane, 
repressing the generation of an action potential. Additionally, neurotransmitter binding can 
mediate short-term changes, such as changes in postsynaptic potential or long term changes 
through the activation of signalling cascades. 
G-protein-coupled receptors (GPCRs) are one of the primary ways to regulate the 
neurotransmitter release at the presynaptic terminal (Lovinger, 2008). It is known that the 
activation of GPCRs at the presynaptic terminal can reduce neurotransmitter release (Lovinger, 
2008). This involves the activation of G-proteins that regulate different inhibitory mechanisms 
such as inhibition of voltage-gated Ca2+ channels, activation of K+ channels, or directly regulating 
vesicle fusion processes (Lovinger, 2008). For example, endocannabinoids can bind to the GPCR 




decrease in neurotransmitter release (Lovinger, 2008). Moreover, GPCRs are also known to act on 
the signalling molecules such as cyclic adenosine monophosphate (cAMP), who can in turn act on 
cAMP-response element-binding protein (CREB) that regulates the expression of genes known to 
be involved in the synaptic development (Wang et al., 2018). 
Additionally, neurotransmitters play a central role in shaping the nervous system throughout 
development (Herlenius and Lagercrantz, 2004; Huntwork and Littleton, 2007). For example, 
spontaneous neurotransmitter release that occurs independently of an action potential at synapses 
is regulated by complexin (cpx), a SNARE complex–binding protein. Studies have found that the 
cpx null mutants have increased spontaneous neurotransmitter and nerve terminal overgrowth 
(Huntwork and Littleton, 2007; Cho et al., 2015). This suggests that synaptic neuronal connections 
may be, in part, regulated by the spontaneous neurotransmission.  
1.2 Development and neurobiology of Drosophila: 
Drosophila has been a favoured model organism for neuroscientists because it possesses ideal 
features for an experimental organism. It has a shorter life span, small size, cheap to maintain in 
large numbers and is anatomically simple. In modern times, immunohistochemistry-based 
anatomy with electrophysiological studies has demonstrated that the Drosophila larval 
neuromuscular junction (NMJ) is an excellent genetic model to study synaptic function and 
development (Harris and Littleton, 2015; Shin et al., 2018). Easy genetic manipulations in 
Drosophila have made it an extremely appealing model system. The systematic large-scale 
screening of early development of the Drosophila neuromuscular system could serve as a model 
to study axonal growth and synapse formation (Miller et al., 2012; Shin et al., 2018).  




For decades, the fruit fly Drosophila melanogaster, in order Diptera and family 
Drosophilidae, has been used as a model organism for biological research because of the high 
degree of evolutionary conservation (Bellen et al., 2010; Hales et al., 2015). For the last 50 
years, Drosophila has been systematically used to understand and discover principle mechanisms 
underlying fundamental biological processes such as development, cell-cycle regulation, 
signalling pathways, and synaptic growth and functions (Shin et al., 2018). Also, fly genetics has 
been transformed with the advent of molecular technology, gene sequencing, transgenic knock-
down constructs and recombination-based strategies for the generation of mutants (Hales et al., 
2015).  
Drosophila is easily cultured in the lab and can have many offspring in a short generation 
period (Shin et al., 2018). The process of development from fertilized egg to adults requires an 
average of 9-10 days (Fig. 1.2). After fertilization, embryogenesis is completed in approximately 
24 hours, followed by three larval stages, with first two lasting one day and last stage lasting two 
days. Thus, after five days of fertilization, Drosophila larvae metamorphose within a hard pupal 
case, with steroid hormone ecdysone playing a vital role during this transformation (Hales et al., 
2015; Shin et al., 2018). Drosophila remains in the pupal case for 4-5 days and emerges as an 
adult, requiring an additional 8-12 hours to sexually mature (Hales et al., 2015). 
Drosophila was the second organism to be sequenced, following only C. elegans, with 
approximately 13,600 genes (McGurk et al., 2015). This enabled the fly community to establish 
and access large datasets that contain information on the Drosophila genome, transcriptome, 
regulatory elements, thus making Drosophila an excellent experimental system to answer 
questions about the development and function of the genes in an organism. Since most of the 




Drosophila genetic analysis is critical for research in human health (McGurk et al., 2015; Hales et 
al., 2015). This is because, at the basic level, the molecular mechanisms associated with pathways 
such as neural responses in Drosophila are shared with humans, thus making it an invaluable tool 
(McGurk et al., 2015). 
1.2.2 Neuromuscular junction of Drosophila: 
Drosophila NMJs are an ideal system to examine cellular and molecular mechanisms that 
underlie developmental processes (Shin et al., 2018). NMJs have a number of synaptic 
connections where information is transmitted from the presynaptic endings of motor neurons to 
the muscle. Abdominal segments of larval NMJs are composed of simple and easily accessible 
overlapping, striated fibres attached to the surface of body wall at a specific location (Keshishian 
et al., 1996; Miller et al., 2012). Each muscle in larvae is a multinucleated cell, formed by nearby 
myoblasts merging (Keshishian et al., 1996; Miller et al., 2012). During the late stages of 
embryonic development, motor neurons spread their axons into the musculature (Miller et al., 
2012). The segmental, intersegmental nerve roots and the transverse nerve are the three pathways 
that the motor neurons take to leave the central nervous system (Keshishian et al., 1996; Menon et 
al., 2013), following a genetically determined route to a specific muscle fibre. The axonal growth 
cones extend to the target muscle, where then growth cones differentiate into the presynaptic 
terminal (Miller et al., 2012). Thus, by the last embryonic development stage, a functional NMJ 
containing synaptic boutons forms on each muscle fibre (Menon et al., 2013). 
The larval NMJ consists of a simple configuration consisting of abdominal hemisegments 
from A2 to A7, of around 36 motor neurons and 30 muscles (Landgraf and Thor, 2006), in a highly 
stereotyped and segmented way. These boutons in Drosophila mainly release glutamate as an 




neuropeptide called proctolin (Keshishian et al., 1996; Menon et al., 2013). Additionally, larval 
motor neurons fall into three classes: type I, type II and type III, based on the size of their boutons 
and anatomy, as depicted in figure 3. Type I boutons are glutamatergic, type II and III are 
modulatory and use other neurotransmitters (Atwood et al., 1993). There are two main types of 
types I of glutamatergic motor neurons: 1b and 1s. Type 1s and 1b are both motor excitatory and 
glutamatergic and are subdivided into 1b (3-5μm) and 1s (1-3μm) based on the size, as depicted 
in figure 1.3 (Atwood et al., 1993). Additionally, type II presynaptic terminals are smaller. They 
have longer branches than type I terminals and type III display elongated or elliptical presynaptic 
terminals with intermediate size between type I and II (Perez-Moreno and O’Kane et al., 2019). 
Most synaptic studies have focused on performing the experimentation on the larval abdominal 
ventral longitudinal muscles of muscles 6 and 7. At this section of the larvae, the NMJ is large and 
positioned on the surface of dissected preparation (Menon et al., 2013).  
1.2.3 Approaches to study Drosophila NMJ development: 
Drosophila mutants and transgenic flies have been instrumental in the investigation of the 
nervous system's complexity through sophisticated genetic manipulations. The GAL4-upstream 
activating sequence (UAS) system can be used selectively express transgenes in specific tissues 
(Fig. 1.4). To express the desired transgene in a particular tissue, driver flies that contain the tissue-
specific promoter of upstream of the gene encoding the yeast GAL4 transcription factor and flies 
containing the corresponding UAS binds that can bind to GAL4 (Brand and Perrimon, 1993). Thus, 
the transgenic flies that only contain one of the two constructs do not express the desired genotype. 
However, when crossed, GAL4 drives the expression of the UAS transgene, which allows the 




fluorescent effectors such as GFP reporters can easily be used to visualize anatomy or 
electrophysiological recordings using the GAL4/UAS system.  
1.3 Synaptic membranes:  
 Like other cellular membranes, the presynaptic and postsynaptic plasma membranes are 
composed of both lipids and proteins (Lasiecka et al., 2008; Sezgin et al., 2017). The phospholipid 
bilayer serves as the foundation of the synaptic membrane by serving as a barrier between two 
aqueous counterparts of inside and outside of the cell (Sezgin et al., 2017). This bilayer structure 
of the membrane contains hydrophobic fatty acid chains, glycolipids, phospholipids, and 
cholesterol distributed between two leaflets of the plasma membrane (Lasiecka et al., 2008). Even 
though lipids form the synaptic membrane's structural foundation, it is the proteins embedded in 
the membrane that carry out the specific functions. Thus, proteins such as adhesion molecules, G 
protein-coupled receptors, signalling receptors, voltage-gated channels, ligand-gated channels, and 
other functional protein complexes allow the signal propagation in neuronal circuits (Lasiecka et 
al., 2008; Sezgin et al., 2017). Therefore, the synaptic plasma membrane, along with its 
component, is crucial for performing specific functions such as action potential transmission, 
neurotransmitter release, and development. 
1.3.1 Synaptic membrane lipids: 
Normal neuronal function is dependent on the proper assembly of membrane lipids for 
lipid-based signalling. Lipids can be divided into simple lipids such as fatty acid and sterols such 
as cholesterol, and complex lipids such as glycerophospholipids and sphingolipids (Fahy et 
al., 2005). The role of lipids at the membrane is dependent on its unique biophysical properties. 
Lipids are small amphipathic molecules that can self-assemble in water. They are composed of a 




curvature. Additionally, the presynaptic membrane can remodel their membrane phospholipids by 
using phospholipases to control biophysical properties such as curvature, fluidity, thickness, and 
through the release of signalling molecules (Puchkov and Volker, 2013; Lauwers et al., 2016). 
At synapses, lipids have also been known to play a significant role in synaptic vesicle 
endocytosis and processes. Synaptic plasma membranes are extensively reconstructed for the 
formation of synaptic vesicles during endocytosis, the release of neurotransmitters through fusion 
with the membrane, and synaptic events that require the opening of ion channels. Proteins involved 
in the priming and docking of synaptic vesicles tend to bind to the negatively charged lipids in the 
membrane, such as phosphatidylinositol phosphates (Lauwers et al., 2016). Moreover, exocytosis 
also requires synaptic membrane fusion between the vesicles and the plasma membrane. SNARE 
complexes (Fig. 1.1), composed of synaptobrevin, syntaxin, and SNAP-25 proteins, regulate this 
process through the assistance of membrane lipids and proteins (Rohrbough and Broadie 2005). 
For example, phosphatidylinositol phosphates and phosphatidylserine bind to synaptobrevin and 
syntaxin during vesicle docking, assisting in the regulation of synaptic vesicle exocytosis 
(Darios et al., 2007). Furthermore, phosphatidylinositol (PtdIns), membrane lipids that can give 
rise to seven different PtdIns through phosphorylation at three different positions, are also known 
to regulate transmembrane and peripheral membrane proteins at terminals (Lauwers et al., 2016). 
PtdIns are known to regulate calcium-stimulated exocytosis, clustering of syntactic vesicles in the 
presynaptic terminal, and playing a role in clathrin-dependent endocytosis (Lauwers et al., 2016). 
Hence, PtdIns play a vital role in driving the synaptic vesicle cycle, regulating ion channels, and 
regulating presynaptic protein interaction.  
Through biochemical experiments and observations on cholesterol’s close association with 




hypothesis (Korade and Kenworthy, 2008). This hypothesis states that the cholesterol and 
sphingolipids are part of membrane nanodomains located in the plasma membrane (Korade and 
Kenworthy, 2008; Maekawa and Fairn, 2015). Thus, lipid rafts are specialized membrane 
microdomains involved in the assembly of signalling molecules, facilitating cell signalling 
cascades, regulating exocytic and endocytic pathways, controlling fluidity of the membrane, 
trafficking and sorting of proteins, and regulation of different cellular processes such as 
neurotransmitter release (Tsui-Pierchala et al., 2002; Korade and Kenworthy, 2008).  
It has been proposed that lipid rafts are the structures that regulate the neurotransmitter 
signalling through clustering components of signalling cascades (Tillman and Cascio, 2003). The 
localization of these proteins and cholesterol in lipid rafts affects the efficiency of neurotransmitter 
receptors and transporters. It has been studied that altered sterol production leads to altered 
organization and composition of lipid rafts, resulting in a disruption in neurotransmitter release 
(Tillman and Cascio, 2003; Allen et al., 2007). Cholesterol-synaptophysin-synaptobrevin 
interaction is thought to recruit and segregate essential synaptic vesicle-specific proteins from the 
plasma membrane (Thiele et al., 2000). Although progress has been achieved in the understanding 
components of lipid rafts, we still have little insight into mechanisms through which they might 
be involved in neuronal functioning. 
1.3.2 Role for sphingolipids at synapse: 
 Neuronal plasma membranes and endomembrane systems are also enriched in synaptic 
membrane lipids called sphingolipids and their derivatives. Sphingolipids are composed of a long 
chain of amino-alcohol sphingosine, acting as signalling centres of membranes (West et al., 2018). 
It is known that the sphingolipids self-aggregate into membrane domains with cholesterol 




localization of neurotransmitter receptors, synaptic vesicle exocytosis, axonal outgrowth, protein 
localization and responses to oxidative stress (Puchkov and Volker, 2013; West et al., 2018). 
Changes in sphingolipid mechanistic pathways have been associated with neuronal plasticity 
disruptions (Hussain et al., 2019). Disorder in sphingomyelinase-2, which hydrolyzes 
sphingomyelin to ceramide, is known to modulate synaptic activity, in part by controlling the 
function of excitatory postsynaptic receptors (Tabatadze et al., 2010; Hussain et al., 2019).  
           In vitro studies on sphingolipid/cholesterol microdomains have implicated sphingolipids in 
neuromuscular synaptic development (West et al., 2018). Recessive and dominant mutations in 
serine palmitoyltransferase long chain base subunits (SPT2/SPTLC2), which is essential for 
sphingolipid synthesis, results in significant perturbations to gross morphology of NMJ structure. 
In addition, EMS induced point mutation in the Drosophila SPTLC2 gene, lace, also decreases 
synaptic bouton number and results in an increase in bouton size with no changes in the 
ultrastructure of the synapse (West et al., 2018). Huang et al., (2018) also showed that mannosyl 
glucosylceramide (MacCer), a species of glycosphingolipid (GSL), promotes synaptic bouton 
formation at the NMJ. These findings demonstrate that sphingolipid synthesis is required at the 
Drosophila NMJ to regulate synaptic structure and development.       
1.3.3 Cholesterol: 
Among the presence of a variety of phospholipids and sphingolipids in a synaptic 
membrane, cholesterol plays a unique role. Due to its rigid hydrophobic structure and small 
headgroups, cholesterol can flip-flop between the bilayer membrane and be easily inserted and 
removed by protein carriers (Maekawa and Fairn, 2015). Additionally, due to the hydrophobic 
nature of its ring, cholesterol can tightly insert with phospholipids and sphingolipids, thus serving 




integrity, and fluidity of plasma membranes and modulates the activity of intercellular signal 
transduction pathways through association with proteins such as the Hedgehog protein (Kuwabara 
and Labouesse, 2002). Moreover, it serves as a precursor to steroid hormones, thus playing a vital 
role in developmental processes (Huang et al., 2007). In Drosophila, sterols accumulate in high 
concentrations in the salivary glands, midgut, imaginal discs, brains, trachea, and ovaries 
(Huang et al., 2007). In mammals, cholesterol is essential for the synthesis of hormones, assembly 
of the cell membrane, and formation and regulation of lipid rafts, which are necessary for cellular 
signalling and synaptic transmission (Vance, 2012). Due to the importance of cholesterol, different 
analytical methods to analyse cholesterol can be used for visualization and extraction.  
1.3.3.1 Tools for visualizing cholesterol localization:  
Localization of cholesterol can be studied by using cholesterol-binding tools. Filipin, a 
fluorescent polyene macrolide, can bind to free 3-B-hydroxysterols such as ergosterol and 
cholesterol, and can accordingly be used to visualize cellular cholesterol (Friend and Bearer, 
1981). Limitations concerning the use of Filipin as a marker is that the efficacy depends on the 
microenvironment and its fails to differentiate between cholesterol located in cytosolic or exofacial 
leaflets of the plasma membrane (Pfrieger et al., 2003; Maekawa and Fairn, 2015), thus making it 
a less ideal cholesterol biomarker. 
In this study, I used domain four (D4H) of the theta-toxin made by Clostridium 
perfringens to construct a genetically encoded cholesterol biosensor to monitor the distribution of 
endogenous cholesterol. Perfringolysin O (PFO) theta-toxin is a cytolysin known to bind to 
cholesterol and makes pore formation (Shatursky et al.,1999; Maekawa, 2017). PFO is a protein 
that contains four domains, and it is domain 4 (D4) that recognizes the hydroxyl group at position 




its cytotoxicity and increase affinity, researchers have developed cholesterol biosensors named D4 
to visualize the distribution of cholesterol in plasma membranes (Maekawa and Fairn, 2015; 
Maekawa, 2017). 
The fourth domain is a 13 kDa small size segment of this toxin that accurately detects the 
cholesterol in the exofacial leaflet of the membrane using microscopy (Maekawa and Fairn, 2015). 
The addition of GFP-tagged to D4 can then be utilized to analyze cholesterol’s subcellular 
distribution. Furthermore, we specifically used D4H, a D4 domain mutant, which has a higher 
affinity for cholesterol in cells (Maekawa and Fairn, 2015). It’s the D4D434S mutant, named D4H, 
that is used to image cholesterol in the cytosolic leaflets of the plasma membrane (Maekawa and 
Fairn, 2017). Thus, this method to detect cholesterol overcomes the limitation of differentiating 
cholesterol localization in the exofacial and cytosolic leaflets of the membrane and is ideal for 
live-cell or time-lapse imaging, which is not possible with Filipin (Maekawa and Fairn, 2015). 
Hence, D4H is an ideal tool to visualize cholesterol distribution to uncover a new understanding 
of cholesterol in synaptic membranes compared to other available methods. 
1.3.3.2 Cholesterol-depleting agent: 
Extraction of cholesterol from membranes has often been used to study cellular signalling, 
membrane fluidity, proteins sorting and trafficking, and membrane permeability (Ilangumaran and 
Hoessli, 1998; Mahammad and Parmryd, 2015). Cholesterol depletion can be achieved through 
metabolic inhibitors that causes disruption of its biosynthesis such as compactin, lovastatin or 
sqalestatin. Otherwise, cholesterol deficient medium or chemicals such as digitonin and saponin 
can also be used to extract cholesterol (Mahammad and Parmryd, 2015). Inhibition of cholesterol 
synthesis or culture cells in poor cholesterol medium requires treatment over days, allowing time 




usually suitable for working with live cells for example digitonin is a detergent that can make 
membranes porous (Mahammad and Parmryd, 2015). Therefore, cyclodextrins (CDs) have 
frequently been used for cholesterol extraction acutely or chronically in vivo or in vitro since they 
can work fast, don’t degrade, and are compatible with live cell experiments (Ilangumar and 
Hoessli, 1998; Swaroop et al., 2012; Mahammad and Parmryd, 2015). CDs are water-soluble 
oligosaccharides that contain a hydrophobic cavity to sequester cholesterol in their hydrophobic 
core (Fig. 1.5). Unlike other cholesterol-binding agents, CDs are surface-acting and selective for 
membrane cholesterol agents (Ilangumaran and Hoessli, 1998). Additionally, there are three 
different cyclodextrins (α, β and γ -cyclodextrins) used to change the plasma membrane's sterol 
composition. However, it's the methyl-β-cyclodextrin (MβCD) that has been studied to selectively 
extract cholesterol (Ilangumaran and Hoessli, 1998). 
1.3.3.3 Effects of cholesterol on kinase activity: 
Cholesterol is thought to affect the activity of kinases (Smith et al., 2010). However, 
directly testing the effects of cholesterol extraction on kinase activity has been difficult to do in 
vivo. The development of genetically encoded reporters of kinase activity allows for more direct 
evidence of the effects of cholesterol on kinase activity. A recent study measured PKA activity 
using the separation of phases-based activity reporter of kinase (SPARK)-PKA, a GFP-based 
kinase reporter (Fig. 1.6) that phase-separated upon kinase activation forming fluorescent droplets 
(Zhang et al., 2018). In this SPARK-based PKA, reporter flies contain a peptide sequence known 
as forkhead-associated domain 1 (FHA1), which is specifically phosphorylated by PKA. Also, this 
FHA1 domain is fused with homo-oligomeric tags (HOTags) and PKA reporter gene. Therefore, 
to allow for a PKA activity-dependent activity visualization, when PKA is activated, it induces the 




separation and formation of fluorescent droplets. However, when the kinases are inactivated, there 
is a diffuse fluorescence. Consequently, transgenic flies with the SPARK reporter can be used to 
detect kinase activity.  
1.4 Function of cholesterol at synapse: 
Cholesterol is essential for the normal function of neuronal membranes. Studies have found 
cholesterol in microdomains influences the distribution of a number of presynaptic and 
postsynaptic proteins that are involved in synaptic transmission. Cholesterol is thought to be 
enriched at presynaptic components such as synaptic vesicles, active zones (sites of exocytosis) 
and periactive zone (sites of endocytosis) and postsynaptic terminals.  
1.4.1 Cholesterol in presynaptic terminals: 
Lipid rafts in the presynaptic terminals contain an elaborate assembly of lipids and proteins 
that are essential components of exocytosis machinery for transport and synthesis of 
neurotransmitter vesicles. Membrane cholesterol content changes membrane fluidity and structure 
(Igbavboa et al., 1996). Inner leaflet of presynaptic terminal membrane's contain eight-fold more 
cholesterol than its outer leaflet, thus resulting in the asymmetric distribution in the presynaptic 
membrane (Igbavboa et al., 1996). Biochemical studies through experiments such as freeze-
fracture electron microscopy on frog NMJs indicted a high amount of cholesterol in active zone 
and a low quantity in the adjacent areas that are enriched in the intramembrane particles (Ko et al., 
1986). An additional study by Surchev et al., (1995) on the rat cerebral cortex also indicated the 
presence of cholesterol at presynaptic terminals and an absence from intramembrane particles rich 
zones. Moreover, Surchev et al. (1995) also established that the cholesterol concentration at the 





1.4.2 Cholesterol in postsynaptic terminals: 
The postsynaptic membrane and postsynaptic density contain proteins that allow for 
postsynaptic signal transduction in a cholesterol-dependent manner. Postsynaptic neurotransmitter 
receptors are linked to rafts, such as nicotinic acetylcholine receptors (AChRs), α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors and N-methyl-D-
aspartate (NMDA) receptor subunits (Pfrieger et al., 2003). For example, AChRs from cultured 
chicken ciliary ganglion neurons were found to disperse when cholesterol was extracted using 
MβCD (Brusés et al., 2001). This suggests that cholesterol may facilitate the clustering of 
postsynaptic receptors via lipid rafts.  
1.4.3 Effects of dysregulation of cholesterol biosynthesis and trafficking:  
In mammals, cholesterol synthesis starts in the endoplasmic reticulum and is trafficked in 
anterograde transport vesicles from the trans-Golgi network with various transporter assistance. 
Cholesterol is synthesized from the conversion of acetyl-CoA to 3-hydroxy-3-methylglutaryl-CoA 
by HMG-CoA synthase, which is then converted to mevalonate by HMG-CoA reductase, then 
followed by series of 19-step enzymatic reactions (Maxfield et al., 2010). In contrast, 
in Drosophila and all other insects, cholesterol is unable to be synthesized from simple precursors 
(Huang et al., 2005; Niwa et al., 2011). Their genome lacks the enzymes for de novo synthesis. 
Thus, they must take cholesterol directly from diet to survive. 
It is studied that on a cholesterol-free diet Drosophila, does not develop from the first-instar 
larva to the second-instar larva (Parkin and Burnet, 1986), thus implicating the need of cholesterol 
for larval growth. This suggests that even though insects don’t synthesize cholesterol, they must 
have genetic mechanisms regulating the uptake, trafficking, and conversion of cholesterol to other 




needed for molting and properly developing and reproducing, cholesterol is obtained from food 
(Huang et al., 2007), thus indicating that cholesterol is an essential component of 
Drosophila development.  
1.4.3.1 Drosophila Niemann-Pick type C genes for cholesterol homeostasis and steroid 
biosynthesis: 
Previous studies have indicated that the Niemann-Pick type C1 (NPC1) in Drosophila is 
involved in cholesterol and lipid homeostasis and is a vital component to synthesize the molting 
hormone (20E) (Phillips et al., 2008). A genetic approach to explore the function of cholesterol 
in Drosophila has shown that the NPC1 mutants have molting defects and homozygotes do not 
develop beyond the first-instar larvae stage because of a deficiency in the molting hormone 20E, 
since the precursors of ecdysone biosynthesis are cholesterol and 7-dehydrocholesterol (Huang et 
al., 2007). This lethality can be rescued by feeding NPC1 mutant larvae excess 20E or its two 
precursors: cholesterol or 7-dehydrocholesterol. NPC1 promotes efficient intracellular trafficking 
of sterols to the ER, mitochondria, and organelles of ring gland cells for proper development 
(Huang et al., 2007). Mutation in the NPC2 gene also results in an abnormal distribution of sterol 
in many cells in Drosophila but does not cause death (Huang et al., 2007). In addition to the defect 
in the cholesterol levels, NPC1 mutants have neuronal and behavioural abnormalities such as a 
shorter life span compared to the wild type and large vacuoles in the brain, indicating 
neurodegeneration (Huang et al., 2007). This suggests that cholesterol is vital for proper 
development. 
1.4.3.2 DHR96 nuclear receptor regulates cholesterol homeostasis: 
DHR96, a Drosophila nuclear receptor responsible for cholesterol homeostasis, is essential 




nuclear receptor binds to cholesterol and is known to be essential for survival in a low cholesterol 
diet and to maintain cholesterol homeostasis during development on a high cholesterol diet 
(Horner et al., 2009). Research indicates that there is an increase in DHR96 activity level in low 
cholesterol mediums, thus protecting cells in low cholesterol situations (Horner et al., 2009; 
Niwa et al., 2011). Furthermore, dietary cholesterol is known to regulate the transcription of genes 
and acts to regulate lipid metabolism (Kalaany and Mangelsdor, 2006). Investigations conducted 
on DHR96 mutants grown in low-cholesterol mediums have found that certain genes which are 
known to play central roles in cholesterol metabolism and transport are up-regulated in response 
to cholesterol levels (Horner et al., 2009). Additionally, DHR96 mutants grown on a low-
cholesterol diets have been found to arrest their development and die within few days (Horner et 
al., 2009), thus indicating that cholesterol is necessary for larval development. 
1.4.3.3 Oxysterol binding protein (OSBP) for cholesterol transport, signalling and 
metabolism: 
Within the cell, cholesterol and other sterols are distributed unevenly, with the most 
localization occurring in the plasma membrane (Ma et al., 2010). This uneven distribution of 
sterols usually involves both the vesicular and non-vesicular trafficking systems (Ma et al., 2010). 
The oxysterol binding protein (OSBP) family, which binds to sterols, is involved in the 
intracellular non-vesicular trafficking of cholesterol (Alphey et al., 1998; Ma et al., 2010; 
Olkkonen, 2004). For example, OSBP anchors to the Golgi apparatus by interacting with 
phosphatidylinositol 4-phosphate (PI4P) and GTPase ADP-ribosylation factor 1 (ARF1) in the 
membrane. OSBP also binds specifically to cholesterol for its transport, vesicle trafficking, and 
cellular signalling (Ma et al., 2010). Knockdown of these proteins results in defects in the 




organelles (Alphey et al., 1998; Ma et al., 2010). In Drosophila, OSBP transports sterols between 
the intracellular vesicles and the plasma membrane and the lack of sterols in OSBP mutants results 
in the absence of mature sperm, which can be restored when supplementing the medium with 
cholesterol to recover some fertility and produce more offspring (Ma et al., 2010). Interestingly, 
VAP33A, a binding partner of OSBP in Drosophila, is known to affect synaptic growth and 
neurotransmitter release through interactions with microtubules and the presynaptic membrane at 
the Drosophila larval NMJ (Pennetta et al., 2002). Acyl coenzyme A, cholesterol acyltransferase 
genes, and steroidogenic acute regulatory proteins are some of the other cholesterol regulating 
elements found in Drosophila for cholesterol regulation (Niwa et al., 2011). 
1.5 Regulation of neurotransmission release: 
 Controlling levels of cholesterol in the membrane is essential for the normal functioning of 
many membrane proteins involved in synaptic transmission, such as ion channels, receptors, and 
transporters. Thus, alteration of cholesterol content is known to change the fusibility of membrane 
and activity of these proteins (Lang, 2001). Internalization, localization, and trafficking of 
neurotransmitter receptors are also known to be significantly influenced by cholesterol depletion. 
Cholesterol is also vital for the maintenance of synaptic organization, processes of synaptogenesis, 
and synaptic vesicle recycling (Pfrienger, 2003).  
1.5.1 Effects of cholesterol on evoked neurotransmitter release: 
 Various studies have applied electrophysiological and optical techniques to examine the 
effects of cholesterol depletion on evoked neurotransmitter release. Work by Zamir and Charlton 
(2006) revealed that the cholesterol extraction by MβCD blocked evoked neurotransmission at 
crayfish neuromuscular junction. Their results demonstrates that cholesterol depletion 




halting the action potential-dependent evoked neurotransmitter release. Smith et al. (2010) also 
observed a decrease in the amplitude of EPSCs in cerebellar neurons and reduced paired-pulse 
ratio after cholesterol extraction, suggesting an increased release probability. These studies 
indicate that the blockade of evoked transmitter release by cholesterol extraction is maybe due to 
blockade of action potential propagation. Study conducted by Dason et al. (2010) found that the 
effect of acute sterol depletion in Drosophila larval NMJ enhanced evoked neurotransmitter 
release. The increase in the evoked transmitter release suggests that the application of MβCD does 
not impair action potential propagation in Drosophila motor neurons. In summary, these findings 
indicate that acute cholesterol removal by MβCD results impairs action potential propagation and 
increase evoked neurotransmitter release.  
1.5.2 Effects of cholesterol on spontaneous neurotransmitter release: 
 Corresponding to evoked release, recent studies of the presynaptic machinery have produced 
results that support the finding that MβCD application augments spontaneous neurotransmitter 
release. Extraction of cholesterol with MβCD increased the frequency of mini excitatory 
postsynaptic potentials at the crayfish NMJ (Zamir and Charlton, 2006). Consistent with these 
findings, cholesterol extraction from cultured hippocampal and cerebellar neurons also increased 
spontaneous neurotransmitter release (Wasser et al., 2007; Wasser and Kavalali, 2009; Smith et 
al., 2010). Likewise, the effect of acute cholesterol depletion at the Drosophila larval NMJ also 
enhanced the spontaneous neurotransmitter release (Dason et al., 2010). These studies demonstrate 
that the level of cholesterol plays an essential role in limiting spontaneous synaptic vesicle release 
at synapses (Zamir and Charlton, 2006; Wasser et al., 2007, 2009; Dason et al., 2010, 2014; 




These changes in synaptic transmission, especially the significant increase in the 
spontaneous release, could be because of alterations in cholesterol-dependent protein interactions, 
indicating a protein-mediated inhibition of spontaneous fusion regulated by the presence of 
cholesterol. Cholesterol appears to play critical modulatory roles in both spontaneous and evoked 
neurotransmitter release. However, detailed mechanisms of this phenomenon have not yet been 
identified. 
1.5.3 cAMP-PKA pathway regulates neurotransmitter release: 
Studies have implicated the role of the cAMP-PKA pathway in the regulation of 
neurotransmitter release. cAMP analogs are known to increase transmitter release regulated by a 
PKA-dependent increase in the number of synaptic vesicle (Baba et al., 2005). Moreover, PKA is 
known to mediate synapsin phosphorylation, which modulates neurotransmission (Menegon et al., 
2006). 
A study by Yoshihara et al. (2002) investigated the effect of cAMP on spontaneous and 
evoked synaptic currents. To increase the cAMP level, they used forskolin, an activator of adenylyl 
cyclase, and CPT-cAMP, a cAMP analog. They found that when either one was added to the 
treatment group, there was an increase in the spontaneous synaptic currents. Furthermore, it is 
thought that this forskolin–cAMP-dependent increase in spontaneous frequency is potentially 
through activating PKA.  
Studies in Drosophila have demonstrates that there is a drastic increase in the spontaneous 
release in cpx null flies (Cho et al., 2015). Interestingly, the C terminus of Cpx is known to be 
phosphorylated by PKA, thus indicating that it might be controlled through post-translational 
modifications. Cho et al. (2015) showed that at the Drosophila NMJs, enhancement of 




required for activity-dependent synaptic growth. The C terminus of Cpx that is involved in the 
inhibition of the spontaneous fusion and most likely interacts with lipid membranes through a Cpx 
7B. Cpx 7B is an amphipathic helix and is probably involved in the regulation of protein/lipid 
association with the plasma and is a site for PKA phosphorylation. Research indicates that the 
PKA phosphorylation of Cpx selectively enhances spontaneous release. And this enhanced 
spontaneous release is required for activity-dependent synaptic growth (Cho et al., 2015) It is 
possible that the cAMP–PKA cascade may influence synaptic vesicle fusion process through 
various methods such as synaptic vesicle mobilization and translocation, changes in the calcium 
levels through voltage-gated Ca2+ channels and regulation of synaptic vesicle fusion (Cho et 
al., 2015). These studies implicate the role of the cAMP-PKA pathway in the regulation of 
secretory machinery of the presynaptic neuron. 
1.5.4 Cholesterol regulates kinases activity: 
 Protein kinases are critical molecules in many signaling pathways that modulate synaptic 
responses. Neurotransmitter release is controlled in part by various protein kinases, which might 
be sensitive to changes in membrane cholesterol content (Burgos et al., 2004). It is suggested that 
the effects of cholesterol depletion can lead to activation of several protein kinases, which are 
known regulators of neurotransmitter release at presynaptic terminals (Smith et al., 2010; Cabrera-
Poch et al., 2004). Smith et al. (2010) found that in cerebellar neuron cultures, the rate of 
spontaneous neurotransmitter release is increased after cholesterol extraction by a mechanism that 
utilizes the activation of presynaptic protein kinases. Likewise, Teixeira et al. (2012) also studied 
the effect of protein kinase inhibitors on spontaneous and evoked release after MβCD treatment. 




further implicate that presynaptic protein kinases regulate evoked and spontaneous 
neurotransmitter release, which are sensitive to changes in membrane cholesterol content.  
1.5.5 Synaptic vesicles endocytosis:  
The process of synaptic vesicles recycling in following synaptic vesicle fusion is known as 
synaptic vesicle endocytosis. This process is critical to replenish, maintain, and regulate synaptic 
vesicle pools, so that neurotransmitter release can be sustained for a prolonged period. Thus, 
synaptic vesicles undergo endocytosis within the nerve terminal. This requires a constant supply 
of neurotransmitter-filled synaptic vesicles through processes such clathrin-mediated endocytosis 
(Chanaday et al., 2019).  
1.5.5.1 Role of cholesterol during endocytosis:  
Cholesterol has been implicated in mediating endocytosis (Lang et al., 2001; Dason et al., 
2010; Dason et al., 2014). Cholesterol is a required component for receptor-mediated clathrin-
dependent endocytosis (Urs et al., 2005) and is present in synaptic vesicle membranes (Takamori 
et al., 2006). A study by Dason et al. (2010) found that the depletion of cholesterol from synaptic 
vesicles with MβCD decreased vesicle endocytosis and blocked synaptic transmission. Whether 
cholesterol differentially regulates different forms of endocytosis has not been studied, yet these 
results demonstrate that cholesterol is required for synaptic vesicle recycling.  
1.5.6 Cholesterol and activity-dependent synaptic plasticity: 
 Synaptic plasticity is a term used to describe activity-dependent changes in synaptic 
function. For example, long-term potentiation and long-term depression are changes in synaptic 
responses that can be due to changes in the trafficking of receptors at the postsynaptic membrane 
(Kennedy and Ehlers, 2006; Shepherd and Huganir, 2007). Cholesterol is known to regulate the 




Furthermore, the cholesterol content of membranes of mammalian hippocampal neurons changes 
in response to synaptic activity (Sodero et al., 2012; Brachet et al., 2015). For example, Brachet et 
al. (2015) found that the long-term potentiation reduced the cholesterol content of synaptic 
membranes. They observed a significant redistribution of cholesterol from its intracellular 
compartment in the hippocampal neurons. In addition, Sodero et al. (2015) observed that 
stimulation of glutamatergic neurotransmission induces a small but significant loss of membrane 
cholesterol. This suggests that the cholesterol content of synaptic membranes can change in 
response to synaptic activity. 
1.5.6.1 Activity-dependent synaptic growth at the Drosophila NMJ: 
Evidence in developing NMJ of Drosophila larvae have also indicated that there are 
activity-dependent processes involved in synaptic development (Zhong and Wu, 2004). Crawling 
of larvae in food is a simple locomotor behaviour in Drosophila. Ludwig and Cable (2003) 
provided support for the increase in temperatures affects pupal development due to larval 
locomotor activity being modified at different temperatures. Rearing Drosophila larvae at high 
temperatures (30°C) increases larval locomotor activity, resulting in increased synaptic growth 
(Sigrist et al., 2003; Zhong and Wu, 2004). Thus, these studies support that the Drosophila larvae 
raised at higher temperatures have increased locomotion, which results in increased synaptic 
growth.  
1.6 Synaptic development in Drosophila: 
Drosophila glutamatergic synapses at the larval NMJ exhibit developmental plasticity, a 
process through which the neuronal connection changes during development and maturation. 
During development, after the axon growth cone makes contact with the muscle, they differentiate 




the time embryonic development is completed, a few functional synaptic boutons form on each 
muscle at the NMJ (Ruiz- Cañada and Budnik, 2006). As the development progresses, synaptic 
boutons are continuously added at the NMJ. This expansion occurs through either budding from a 
pre-existing bouton, division of a bouton into two, or formation of a bouton from the axonal 
membrane into a new bouton (Menon et al., 2013). This allows the continuous increase in the 
number of boutons during development. Understanding the mechanism involved in governing the 
synaptogenesis at the NMJ is a vital issue in neurobiology.  
1.6.1 Role of cholesterol in synaptic development: 
The formation of the synaptic networks is critical for development and plays a vital role in 
long-term plasticity. Decreasing cholesterol in an embryonic brain could have serious 
consequences such as respiratory distress, reduced body weight, and failure to feed because 
neurons might be more sensitive to cholesterol during development (Funfschilling et al., 2012). In 
mammals, the idea that brain development occurs after differentiation of astrocytes, which are glial 
cells that are known to synthesize cholesterol in the brain, has sparked an interest to discover a 
connection between synaptogenesis and cholesterol (Pfrieger et al., 2003). Pfrieger and Barres 
(1997) investigated whether neurons form synapses in retinal ganglion cells through the release of 
an unknown soluble factor released by astrocytes and oligodendrocytes. Their study identified 
cholesterol to be the unknown soluble factor that promoted synaptic development. 
Experimentation through active chromatographic column fractions, decrease of the cholesterol 
concentration in neuronal cell cultures, and blocking cholesterol uptake via competitive antagonist 
and cytochemical staining all suggested that glial cells release cholesterol that mediated synapse 
development (Pfrieger et al., 2003). Additionally, glial cells are also reported in other studies on 




studies found that cultured CNS neurons' ability to form synapses depends on the availability of 
cholesterol at the synaptic terminals.  
Defects in the synthesis and trafficking of cholesterol can also be shown to affect the 
development of the nervous system. A study by Funfschilling et al. (2012) found that there is a 
critical time window for the synthesis of cholesterol in neurons of the mouse brain during 
development. New neurons are more susceptible to cholesterol deprivation compared to mature 
neurons in cerebellar granule cells in the mouse. Additionally, Molyneaux et al. (2007) suggested 
that older neurons, such as those presented in cortical layers, are more likely to be affected by 
cholesterol deprivation than newer neurons in the upper cortical layers. This shows the complexity 
in which cholesterol affects the neurons. Moreover, Saito et al. (2009) found that ablated activity 
of squalene synthase (SQS), an enzyme for cholesterol production in the neural stem of the 
embryonic central nervous system of a mouse brain, resulted in reduced brain size and neuronal 
atrophy. However, the ventricular zone of the mouse brain did not undergo significant neuronal 
apoptosis. Additional studies have also provided evidence that cholesterol modulates dendrite 
outgrowth, dendritic branching and axonal regeneration (Goodrum et al., 2000; Fan et al., 2002). 
Interestingly, differential effects on neurite outgrowth from hippocampi and cortices of rat 
embryos cells in cell-cultures were found following cholesterol extraction (Ko et al., 2005). They 
found that the cholesterol reduction from hippocampal neurons increases axon and dendrite 
outgrowth, suggesting that the high concentration of cholesterol in these cells functions to 
attenuate neurite outgrowth. In contrast, neurite outgrowth in cultured cortical neurons was 
inhibited when cholesterol was extracted, suggesting that cholesterol plays the opposite role in 
cortical neurons compared to hippocampal neurons. This indicates that cholesterol regulates the 




A recent study using the Drosophila larval NMJ found that supplementing a cholesterol 
chelating agent (MβCD) in food caused a mild developmental delay, but these larvae still 
maintained normal larval and muscle size reduction in the number of synaptic boutons (Huang et 
al., 2018). These larvae had fewer and larger synaptic boutons at the larval NMJ, suggesting that 
cholesterol is required for normal synaptic growth (Huang et al., 2018). This further provides 
evidence regarding the significance of maintaining cholesterol levels for synaptic development.  
1.6.2 Role of cAMP-Protein Kinase A (PKA) cascade in synaptic development: 
  After the formation of synapses, instructions given by presynaptic neurons can increase or 
halt synaptogenesis (Munno et al., 2003). Injecting cAMP into Aplysia sensory neurons is studied 
to induces long-term morphological changes (Nazif et al., 1991). Additionally, cAMP has also 
been known to influence growth cone motility, neurite elongation, and synaptogenesis in cultured 
neurons (Zhong et al., 1992). For example, an experiment on Lymnaea neurons has found that 
number of synapses might require activation of the cAMP-PKA pathway (Munno et al., 2003). 
Additionally, inhibition of the cAMP-PKA cascade has found to affect innervation, indicating that 
presynaptic cAMP-PKA activity might serve to control synapse formation (Munno et al., 2003).  
To study the cAMP-PKA cascade involved in the terminal development, rutabaga (rut1) 
and dunce (dnc1) Drosophila mutants have been previously been used. These two mutants were 
originally discovered for the roles in learning and memory (Yoshihara et al., 2002). The dnc1 allele 
has reduced phosphodiesterase II activity, an enzyme that hydrolyzes cAMP (Byers et al., 1981). 
Thus, cAMP levels in the dnc1 mutants will be elevated due to reduced phosphodiesterase II 
activity. In contrast, the rut1 allele encodes a defect in a subunit of adenylate cyclase; thus, the rut1 
mutation eliminates Ca2+/calmodulin activation of adenylate cyclase, therefore resulting in a 




larval NMJ (Zhong et al., 1992). On the other hand, the rut1 mutant has a decrease in synaptic 
growth because of low cAMP levels (Zhong et al., 1992; Cheung et al., 1999). Additionally, the 
effects of the dnc1 mutant could be counterbalanced by the rut1 mutant, as demonstrated in the 
dnc1 rut1 double mutant (Zhong et al., 1992). Both mutants disrupt different aspects of the cAMP 
pathway. It has also been previously studied that the activation of the cAMP responsive element-
binding protein (d-CREB), which is regulated by cAMP, is involved in the regulation of synaptic 
growth at the larval NMJ (Renger et al., 2000). These results indicate that the cAMP pathway is 
crucial for the regulation of nerve terminal growth and synaptic plasticity via the regulation of 
second messenger cascades.  
PKA is a major downstream mediator of dnc and rut genes and is known to regulate a broad 
spectrum of proteins through phosphorylation. Mutations that changes the two subunits of PKA 
provide a way to manipulate PKA activity levels, but viable alleles of these mutations are subjected 
to behavioral and physiological changes (Renger et al., 2000). A study by Cho et al. (2015) 
provided evidence that PKA-dependent phosphorylation is needed for synaptic structural plasticity 
and nerve terminal growth. Moreover, constitutively active PKA (CA-PKA) is also known to be 
regulating the nerve terminal growth. Third instar larvae that express CA-PKA in presynaptic 
terminals displayed increased nerve terminal growth when compared to controls (Yoshihara et al., 
2005). This suggests that the activity of PKA is critical in the regulation of synaptic growth. In 
summary, these studies demonstrate the role of cAMP-PKA pathway in the regulation of nerve 
terminal growth at the Drosophila larval NMJ.  
A study by Zhong and Wu (2004) used different cAMP pathway mutants to determine the 
mechanism involved in activity-dependent plasticity. They found that the temperature-dependent 




Furthermore, a study by Cho et al. (2015) also provided support for the requirement of PKA-
dependent phosphorylation of Cpx in activity-dependent synaptic structural plasticity and growth. 
Given that the cholesterol content of membranes change in response to synaptic activity (Sodero et 
al., 2012; Brachet et al., 2015) and existing links between the cAMP-PKA pathway (see below) 
and cholesterol, investigating if cholesterol is required for activity-dependent synaptic growth may 
provide further insight into the underlying mechanisms of activity-dependent synaptic growth.  
1.6.3 Cholesterol-dependent effects on cAMP-PKA pathway: 
 The cAMP-PKA pathway is critical for many signaling processes that modulate synaptic 
response and development. Cholesterol depletion can affect the activity of several cAMP-PKA 
pathway components (Burgos et al., 2004; Cabrera-Poch et al., 2004; Smith et al., 2010), which 
are known regulators of various processes at presynaptic terminals. In addition to direct effects on 
protein kinases, cholesterol also regulates the activity of PP2A phosphatase (Wang et al., 2005). 
A study by Whetton, et al. (1983) provided evidence that the depletion of rat liver plasma 
membrane cholesterol inhibits adenylate cyclase activity and results in an increase in membrane 
rigidity. In addition, Ayling et al. (2012) also provided evidence that the distribution and regulation 
of adenylate cyclase depend on the cholesterol in the plasma membrane.  
  It has been well established that the lipid rafts found in the neuronal cell membrane are 
enriched with cholesterol (Sebastião et al., 2013). In addition, studies have also found evidence 
that the components of the cAMP-PKA pathway are embedded in the lipid in membranes. For 
example, Cabrera-Pochase et al. (2004) also established that different protein kinases are 
associated with lipid rafts in rat primary cortical neurons and that the cholesterol depletion of cell 
membranes with MβCD dramatically alters their localization, activation, and signalling. A study 




of G-protein in the cholesterol-based microdomains in membrane. Furthermore, previous studies 
have also provided support that certain GPCRs, G-protein-coupled receptor kinase and catalytic 
subunit of protein kinase A (PKA) are localized into these lipid rafts (Okamoto et al., 1998; 
Steinberg, 2004). Thus, the most plausible mechanistic explanation for cholesterol dependent 
effects on the cAMP-PKA pathway is that lipid raft disruption though cholesterol extraction 
disrupts the activity of one or more cAMP-PKA pathway components. 
 In present study, I hypothesized that cholesterol extraction would reduce synaptic growth 
at the Drosophila larval NMJ. I also hypothesized that this reduced synaptic growth seen following 
cholesterol extraction was due to alternated cAMP-PKA signaling. Additionally, I predicted that 
cholesterol was required for activity-dependent synaptic growth at NMJs. Lastly, to visualize the 
cholesterol localization, I constructed a vector based on domain four (D4H) of the theta-toxin 
produced by Clostridium perfringens to serve as a genetically encoded cholesterol biosensor that 
can be used in Drosophila.  Overall, my goal was to study the cholesterol-dependent effects on 





























Figure 1.1 Proteins at the presynaptic terminal of synapse:  
A schematic drawing of proteins found at the active zones involved during the regulation of 
synaptic vesicle capture (synapsin, actin), docking (SNARE complex), priming (RIM, Rab, 
Munc13) and fusion (synaptotagmin) of synaptic vesicles and voltage-gated calcium channel 
(VGCC) (Bassoon, RBP , RIM , ELKS) at presynaptic terminal in rat neuronal synapses 












































Figure 1.2 Life cycle of Drosophila melanogaster: 
The image depicts the stage of the life cycle of Drosophila, completed in 10 days after the embryos 
are laid on top of the food in vials with food at the bottom and cotton on top. Embryos hatched on 
day 1 and followed by four days for larvae to develop in the food. During days 5-9, larvae 
metamorphosis within the pupal and on day 10, maturation is complete (Adapted from Hales et 











































Figure 1.3 Types of boutons at the Drosophila larval NMJ: 
The image shows Type Ib, Is, II, and III boutons at the Drosophila larvae neuromuscular junction 
indicated by arrows. Note the size of Type 1b and type 1s boutons differ in size where 1s are 
smaller than 1b boutons. Additionally, subsynaptic reticulum that surrounds boutons are labelled 
with Discs-Large (Dlg) antibody (green). Type 1b boutons are surrounded by more subsynaptic 
reticulum membrane as compared to 1s, whereas Dlg is absent in type II and III boutons. 
Presynaptic neuronal membrane are labelled with Anti-HRP (red). Scale bars are 5 μm 









































Figure 1.4 GAL4/UAS System: 
Schematic of a GAL4/UAS system. GAL4 is a yeast transcription factor which activates 
transcription of its target genes by binding to the Upstream Activating Sequences (UAS) sites. As 
seen in the image that the two components are located on two separate lines. The transgenic flies 
that only contain one of the two constructs do not express the desired genotype. Thus to express 
the desired transgene in a particular tissue, flies that contain the tissue-specific promoter of 
upstream of the gene encoding GAL4 transcription factor and flies containing the corresponding 
UAS must be crossed to activate the gene of interest. Hence the expression of GAL4 under a 
particular promoter will result in activation of gene by binding to the UAS sequence (Image 




































Figure 1.5 Extraction of cholesterol by methyl-β-cyclodextrin (MβCD): 
Schematic of cholesterol structure (left) and cholesterol (right) extraction with MβCD (green) 
(bottom). MβCD has been frequently used to deplete cells of cholesterol. MβCD are cyclic 
oligomers of glucose with the ability to sequester cholesterol in its hydrophobic core. Note that 
cholesterol is a hydrophobic molecules thus have a high affinity to bind to hydrophobic core of 







































Figure 1.6 Visualizing Phase Separation-Based Kinase Reporter of Protein Kinase A: 
Schematic representation of SPARK-PKA reporter where P represents the phosphate group (A). 
When PKA is activated, homo-oligomeric tag 3 (HOTag3) phosphorylates and interacts with the 
forkhead-associated domain 1 (FHA1), infused with HOTag3, through the phosphate group. This 
leads to protein-protein interactions, resulting in phase separation and formation of fluorescent 
droplets. Thus, when the kinase is inactivated, there is a diffuse fluorescence (B), and when the 
kinase is activated, there is formation of concentrated fluorescent droplets (C). This method allows 



































2.1 Drosophila stocks and genetics: 
Fly stocks were grown at room temperature (23°C) or 30°C on molasses-based fly food 
medium (1.5% sucrose, 1.4% agar, 3% glucose, 1.5% cornmeal, 1% wheat germ, 1% soy flour, 
3% molasses, 3.5% yeast, 0.5% propionic acid, 0.2% Tegosept and 1% ethanol in water), as 
described in Anreiter et al. (2016). Wandering third-instar larvae were used for all experiments.  
w1118 was used as the control strain (Dason et al., 2009). The dnc1 hypomorphic allele contains an 
ethyl methanesulfonate (EMS)-induced mutation in the dnc gene (Dudia et al., 1976). This 
mutation is known to decrease the phosphodiesterase II activity, leading to a higher concentration 
of cAMP (Zhong et al., 1992). The rut1 allele contains an EMS-induced mutation in the rut gene 
(Livingstone et al., 1984). This mutation eliminates Ca2+/CaM activation of adenylate cyclase, 
resulting in a decrease in its activity (Zhong et al., 1992). The GAL4/UAS system (Brand and 
Perrimon, 1993) was used for neuron-specific expression of transgenes. n-syb-GAL4 (Verstreken 
et al., 2009) or C155-GAL4 (Robinow and White, 1988) were used to drive expression of 
transgenes in neurons. UAS-CA-PKA was used to express a constitutively active PKA (Li et al., 
1995). UAS-CA-PKA/+ and C155-GAL4/+ were also tested as controls for any insertional effects. 
UAS-LactC2-mCherry (LC2-mCherry) was used to visualize phosphatidylserine distribution in the 
presynaptic terminals (Zhuo et al., 2015). UAS-SPARK-PKA was used to visualize PKA activity 
(Zhong et al., 2018). 
2.2 Dissections: 
Dissections of wandering third instar larvae were carried on a glass dish with a magnetic 
strip placed on top with a 4 cm hole in the magnetic strip (Bellen and Budnik, 2002). The larva 
was pinned dorsal side up in the centre of the plate and pinned at the larva's head near the mouth 




(Sigma, St. Louis, MO), which contains L-Glutamine to block glutaminergic synaptic transmission 
and suppresses unwanted contractions of body wall muscles during dissection. A vertical incision 
was made to cut along the dorsal midline from the posterior end to the anterior end. The preparation 
was pinned down flat and tracheal system, internal organs, gut, fat bodies, and connective tissue 
were removed to expose the CNS and musculature. The segmental nerves were cut and the CNS 
was removed. The larva was then rinsed with Schneider's medium to remove any remaining 
unwanted tissues. 
2.3 Immunohistochemistry: 
Immunohistochemistry was performed as previously described by Dason et al. (2014) and 
Cantarutti et al. (2018). Briefly, the dissected larvae were fixed with the Bouin’s fixative (5% 
acetic acid, 9% formaldehyde and 0.9% picric acid) for five minutes. The fixed larvae were then 
washed in a phosphate-buffered saline solution containing 0.2% Triton X-100 (PBT) every fifteen-
minutes for an hour. Following the wash, fixed preparations were incubated in the blocking 
solution (5% goat serum and BSA (1g/50ml) in PBT) for 30 minutes. Subsequently, preparations 
were incubated overnight at 4°C with fluorescein isothiocyanate (FITC)-conjugated anti-
horseradish peroxidase antibody (HRP, 1:800 dilution, West Grove, PA) to visualize neurons and 
the mouse monoclonal bruchpilot antibody (brp, 1:100 dilution; Iowa Hybridoma Bank, Iowa City, 
IA) to visualize active zones or anti-green fluorescent protein mouse monoclonal 3E6 (GFP, 1:500 
dilution; Invitrogen Thermo Fisher Scientific, Eugene, OR). Primary antibodies were diluted in 
blocking solution. The following day, the dissected larvae were washed with 0.2% PBT for every 
15 minutes for an hour. They were then incubated with the secondary antibody (1:400 dilution; 
Alexa Fluor 594 goat anti-mouse or Alexa Fluor 647 goat anti-mouse; Invitrogen Thermo Fisher 




PBT every 15 minutes for an hour. The samples were mounted on a slide in a drop of Permafluor 
(Immunon, Pittsburgh 59 PA) and stored in a dark area at room temperature for further analysis 
by the confocal microscope.  
2.4 Morphological analysis/confocal microscopy:  
The larval preparations were imaged using Olympus FLUOVIEW FV1000 FV10ASW 
confocal microscope (Heidelberg, Germany). Images were obtained using a 60X oil immersion 
objective (1.42 NA). For all experimentations, images of NMJs of abdominal segment 3 of muscle 
fibres 6 and 7 were used. Images were acquired through a Z scan to make sure that the total number 
of boutons on different planes were imaged. Confocal images were acquired using a step size of 
0.25 μm with an approximate range of 15-32 of the number of slices. 
2.5 Cholesterol extraction assay: 
Cholesterol was depleted using methyl-β-cyclodextrin (MβCD), a cyclic oligosaccharide 
that removes cholesterol from membranes. For chronic cholesterol extraction, flies of different 
genotypes were raised on 5 or 10 mM MβCD (Sigma-Aldrich)-containing molasses-based fly food 
medium as described above. These flies laid eggs on MβCD supplemented food and larvae were 
allowed to develop on this food. For acute cholesterol extraction, 10 mM MβCD was mixed in 
HL6 saline (Macleod et al., 2002) and was directly applied for 20 minutes to dissected larval 
preparations.  
2.6 Plasmids and transformation: 
The pmCherry-C1 vector with D4H (mutant construct of D4, D4D434S) was provided by Dr. 
Fairn (University of Toronto, ON). mCherry-D4H was digested with restriction enzymes EcoRI 
and XhoI (New England BioLabs. Inc) for four hours in a thermocycler (C1000 Touch, 




was run on a 2% agarose gel in 100mL 1xTris-Acetate-EDTA (TAE). Subsequently, the D4H 
domain was gel extracted using the QIAquick® Gel Extraction Kit. Briefly, the D4H fragment 
was cut from an agarose gel with a razer blade and added into the Eppendorf tube. Three volumes 
of Buffer QX1 and 30 μl of QIAEX II were added and incubated for 50°C in a heat block (IsoTemp, 
Fisher Scientific) for 10 minutes. After the agarose gel was dissolved, the sample was washed with 
QXI and the supernatant was removed after centrifuging (Legend Micro 21R Centrifuge, Thermo 
Scientific) for 30 seconds. Samples were then washed twice with 500 μl of Buffer PE and 
centrifuged to remove the supernatant. The pellet was air-dried, and DNA was eluted with 20 μl 
TE buffer (10 mM Tris·Cl, 1 mM EDTA 8.0). Following gel extraction, D4H was amplified by 
PCR using the following pairs of primers: 5'-AAGGGAAAAATAAACTTAGATCATAGTGGA-
3′ (D4H sense primer) and 5′-TTAATTGTAAGTAATACTAGATCCAGGGTAT-3′ (D4H 
antisense primer). The PCR amplification reaction was carried out in PCR C1000 Touch 
Thermocycler (Bio Rad Laboratories, Inc.) at 98°C for 30 seconds, followed by 34 cycles (98°C 
for 10 seconds, 68°C for 30 seconds, and 72°C for 60 seconds) and 72°C for 10 minutes (New 
England Biolabs Phusion High-Fidelity DNA Polymerase).  
 The PCR product was subcloned into the pJFRC14-10XUAS-IVS-GFP-WPRE vector 
(Addgene Plasmid #26223) at KpnI and NotI restriction sites. D4H was first amplified with the 
following primers to create KpnI and NotI restriction sites (underscored in primer sequences): 5’-
TATGCGGCCGCAAGGGAAAAATAAACTTAGATC-3’ (sense primer) and 5’-
ATAGGTACCTTAATTGTAAGTAATACTAGATCC-3’ (antisense primer). The amplification 
conditions included denaturation, annealing and extension steps, as described above. Both the 
pJFRC14-10XUAS-IVS-GFP-WPRE vector and amplified D4H were next digested 




reaction was done using shrimp alkaline phosphatase (rSAP, New England Biolabs). For this, a 20 
μl reaction mixture was prepared with 10x Cutsmart Buffer, rSAP, D4H DNA and ddH2O, and 
incubated at 37 °C for 30 minutes. This was followed by heat-inactivation at 65°C for 5 minutes. 
Subsequently, ligations were performed using New England Biolabs products following the 
manufacturer's directions. Briefly, 20 μl reaction mixture containing T4 10X DNA Ligase 
Reaction Buffer, pJFRC14-10XUAS-IVS-GFP-WPRE vector DNA, Insert D4H DNA and T4 
DNA Ligase was incubated for 3 hours at room temperature and then heat-inactivated at 65°C for 
10 minutes. 
       NEB 10-beta Competent Escherichia coli strain (New England Biolabs, #C3019H) was 
used for the transformation. Competent E. coli cells were removed from a -80°C freezer and 
thawed on ice for 10 minutes. 1 μL of ligated plasmid was added to the cell mixture. This 
suspension was chilled on ice for 30 minutes, followed by heat shock at 42°C for 30 seconds. Cells 
were then placed on ice for 5 minutes. 950 µl of NEB 10-beta/Stable Outgrowth Medium was 
added into cell mixture, followed by incubation at 37°C for 60 minutes. Three 10-fold serial 
dilutions series of the transformation were performed. Each dilution was then spread onto 
ampicillin containing LB agar plates and incubated overnight at 37°C. A PCR colony screen was 
then performed. Single colonies were inoculated in LB medium containing ampicillin and grown 
overnight at 37°C in a shaker. Colonies resulting from each pool were also screened for D4H using 
primer 5'-AAGGGAAAAATAAACTTAGATCATAGTGGA-3′ (D4H sense primer) and 5′-
TTAATTGTAAGTAATACTAGATCCAGGGTAT-3′ (D4H antisense primer) under the 
amplification conditions described above. Colonies that contained the D4H were then further 
tested by extracting the plasmid DNA using the EZ-10 Spin Column Plasmid DNA Miniprep Kit 




bound to EZ-10 Spin Column. The resin was then washed with Wash Solution, and plasmid DNA 
was eluted with Elution Buffer provided in the kit. The resulting plasmids were digested with 
different restrictions enzyme combinations and sequenced using Sanger Sequencing (The Centre 
for Applied Genomics, SickKids, ON) to ensure that the pJFRC14-10XUAS-IVS-GFP-WPRE 
vector containing the D4H sequences was present in the Escherichia coli. This vector will be sent 
out for injection into Drosophila embryos by a company (Bestgene Inc.).  
2.7 Bioinformatics:   
Bioinformatic analyses were conducted using the Geneious Prime 2019.2.3 software 
package (http://www.geneious.com). This software was used to design primers, visualization of 
Sanger Sequencing, nucleotide alignments, design cloning schemes, and restriction enzyme 
digests and ligations predictions. 
2.8 Data analysis and statistics:  
Prism 8 (version 8.4.2 (464); GraphPad Software, LLC.) was used for statistical analysis 
and graphing. Fluorescence intensity was measured for regions of interest using ImageJ software 
(version 1.52k; Wayne Rasband National Institutes of Health, USA). Data were verified for normal 
distribution using the Shapiro-Wilk Normal Test at alpha value of 0.05. Statistical comparisons 
were made using the unpaired two-tail t-test, whereas multiple comparisons were determined by 
one-way ANOVA with Dunnett’s multiple comparison test. Error bars in all figures represent 
standard error of the mean (SEM). Results were considered statistically significant with a P<0.05. 

































3.1 Cholesterol extraction reduces synaptic growth: 
Studies have indicated that neurons form synapses depending on the availability of 
cholesterol during synaptogenesis (Pfrieger et al., 2003; Funfschilling et al., 2012). However, in 
vitro studies have pointed out that reducing cholesterol levels can increase and decrease neurite 
outgrowth in different types of cultured neurons. Specifically, cholesterol reduction from 
hippocampal neurons increased axon and dendrite outgrowth, whereas neurite outgrowth in 
cultured cortical neurons was inhibited when cholesterol was reduced (Ko et al., 2005). A recent 
study using an in vivo Drosophila larval NMJ model showed that supplementing MβCD, a 
cholesterol chelating agent in food caused a reduction in synaptic growth (Huang et al., 2018). 
However, the underlying mechanisms of how reduced cholesterol content of membranes affected 
synaptic growth was not explored. To confirm that cholesterol extraction reduces synaptic growth 
in Drosophila larval NMJ, w1118 larvae (a control strain) were fed-treated 5 mM or 10 mM MβCD 
and compared to controls that were not fed MβCD. Treatment with MβCD has been demonstrated 
to decrease the cholesterol content of membranes in several studies (Dason et al., 2010; Smith et 
al., 2010). I stained NMJs of Drosophila third instar larvae with anti-HRP, a neuronal membrane 
marker, and anti-brp, an active zone marker. Subsequently, I used confocal microscopy to image 
these NMJs and counted the number of synaptic boutons and active zones on segment 3 of muscle 
fibers 6 and 7. These muscle fibers are innervated by two types of axons that consist of type 1b 
and 1s boutons. Boutons from these two motor neurons differ in their morphological and 
physiological properties, with 1b boutons being larger (3-5 μm) than their 1s (1-3 μm) counterparts 
(Atwood et al., 1993). Treatment with 10 mM MβCD caused a significant decrease in the number 
of 1b and 1s boutons compared to the controls and 5 mM MβCD treatment (Fig. 3.1A, C-E). Also, 




two groups (Fig 3.1C, H-J), but otherwise show no obvious morphological changes. Similarly, the 
number of active zones of 1s (Fig. 3.1F) and 1b (Fig. 3.1G) boutons in larvae fed 10 mM MβCD 
were significantly reduced in comparison to controls. Lower concentrations of MβCD (5 mM) had 
no effect on the number of boutons (Fig. 3.1A, B, D, E) or active zones (Fig. 3.1A, B, F, G) as 
compared to controls. Overall, these results suggest that a proper level of cholesterol is required 
for NMJ development. 
3.2 Cholesterol extraction reduces PKA activity: 
Protein kinases are critical molecules in many signaling proteins that modulate synaptic 
responses. Inhibition of the cAMP-PKA cascade is known to influence growth cone motility, 
neurite elongation, and synaptogenesis in cultured neurons (Zhong et al., 1992; Munno et al., 
2003). In addition, the cAMP-PKA pathway is also known to regulate the number of boutons at 
the Drosophila larval NMJ (Cho et al., 2015). Furthermore, changes in the cholesterol content of 
membranes may affect kinase activity (Smith et al., 2010). Therefore, I hypothesized that 
cholesterol extraction may affect PKA activity. To examine the effects of chronic cholesterol 
extraction on PKA activity, I used the GAL4/UAS system to express PKA-SPARK in presynaptic 
boutons of controls, 5 mM and 10 mM MβCD fed-treated larvae. PKA-SPARK is a GFP-based 
kinase reporter (Fig. 1.6) that phase-separates upon kinase activation, forming fluorescent droplets 
(Zhang et al., 2018). Therefore, when kinases are inactivated, there is a diffuse fluorescence. 
However, when kinases are activated, kinase substrate peptide is phosphorylated and then interacts 
with phosphopeptide-binding domain; the resulting multivalent protein-protein interaction leads 
to highly concentrated GFP droplets. Larvae expressing PKA-SPARK were fixed and stained with 
an anti-GFP antibody. NMJs were imaged with confocal microscopy. I measured the fluorescence 




a significant reduction in PKA-SPARK fluorescence in 1b boutons from larvae fed 10 mM MβCD, 
thus indicating that PKA activity was reduced following cholesterol extraction (Fig. 3.2A, C). A 
mild but not statistically significant reduction was seen in 1s boutons (Fig. 3.2B, C). No significant 
differences were found between larvae fed 5 mM MβCD and controls (Fig. 3.2A, B). Therefore, 
this decrease in fluorescence intensity seems to indicate that cholesterol extraction reduces PKA 
kinase activity.  
In addition to studying chronic effects of cholesterol extraction on PKA activity, I also 
examined the effects of acute cholesterol extraction on the PKA-SPARK biosensor. I predicted 
that application of 10 mM MβCD on NMJs after dissection might show a stronger effect on PKA-
SPARK biosensor since MβCD was being directly applied to the NMJ to extract cholesterol. 
Therefore, to determine if the acute application of MβCD might show a stronger effect, I incubated 
dissected third-instar larvae (grown in normal food) in HL6 saline supplemented with 10 mM 
MβCD for 20 minutes before fixing and performing immunohistochemistry. I found a significant 
reduction in PKA-SPARK fluorescence intensity in both 1b and 1s boutons (Fig. 3.2D-G). Acute 
cholesterol extraction resulted in a greater decrease in PKA-SPARK fluorescence than was 
observed when larvae were fed MβCD throughout development. Taken together, these data 
suggest that cholesterol extraction reduces PKA activity.  
3.3 Cholesterol and the cAMP-PKA pathway: 
Drosophila cAMP-PKA mutants are known to display defects in neuronal morphology, 
such as reduced growth cone motility (Kim and Wu, 1996), altered projections of mechanosensory 
neurons, and altered nerve terminal growth at the larval NMJ (Corfas and Dudai, 1991; Zhong et 




extraction was due to alter cAMP-PKA signaling. To elucidate the cellular mechanisms by which 
cholesterol regulates synaptic growth, I used different Drosophila mutants known to be involved 
in the cAMP-PKA pathway.  
Reduced cAMP levels have been revealed to reduce the number of synaptic boutons at the 
Drosophila larval NMJs (Cheung et al., 1999; Zhong et al., 1992). I hypothesized that increasing 
cAMP levels would rescue the reduced synaptic growth seen following cholesterol extraction. The 
dnc gene encodes a phosphodiesterase II enzyme that hydrolyses cAMP (Tully, 1984 and Dudai, 
1988). The dnc1 mutant reduces phosphodiesterase II activity, leading to elevated cAMP levels 
(Byers et al., 1981). Consistent with previous studies (Zhong et al., 1992), I found that when dnc1 
mutants when grown on normal food had significantly more 1b and 1s boutons and active zones 
(Fig. 3.3A, 3.3D-G) than controls grown on normal food (Fig. 3.1). Both 5 mM and 10 mM MβCD-
fed larvae had a significant reduction in the number of boutons and active zones of type 1b or 1s 
neurons in comparison to controls (Fig. 3.3D-G). The reduced synaptic growth was similar to that 
seen in w1118 controls fed 10 mM MβCD (Fig. 3.1). Thus, I was unable to rescue the reduced 
synaptic growth seen in larvae fed 10 mM MβCD by increasing cAMP levels with a dnc1 mutant. 
This may suggest that cholesterol acts on adenylate cyclase or PKA directly; thus, disrupting a 
cAMP-specific phosphodiesterase would not increase cAMP levels nor rescue the synaptic growth 
(see discussion).  
If cholesterol is acting on an adenylate cyclase, increasing PKA activity may rescue the 
reduced synaptic growth seen following cholesterol extraction. To test this hypothesis, I used the 
GAL4/UAS system (Brand and Perrimon, 1993) to express a constituently active PKA (CA-PKA) 
in presynaptic boutons of larvae fed with MβCD. I used C155-GAL4 to drive the expression of a 




and C155-GAL4/+ controls. The w1118 control flies were crossed with UAS-CA-PKA or C155-
GAL4 transgenic flies. In UAS-CA-PKA/+ controls, I found that 10 mM MβCD fed-treated showed 
a significant reduction in type 1b and 1s boutons (Fig. 3.4C, D, E) and active zones in 1s boutons 
(Fig. 3.4C, F) compared to controls. There was a mild, but not significant, reduction in the number 
of active zones in boutons of type 1b neurons of larvae fed 10 mM MβCD (Fig. 3.4G). Larvae fed-
treated 5 mM MβCD showed no significant differences compared to controls (Fig. 3.4B, D-G). 
Thus, cholesterol extraction with 10 mM MβCD reduces synaptic growth in UAS-CA-PKA/+ 
controls, consistent with what I observed with the w1118 controls (Fig. 3.1). Comparable to UAS-
CA-PKA/+ third instar larvae, the C155-GAL4/+ larvae fed-treated 10 mM MβCD,  showed a 
significant reduction in the number of 1b and 1s boutons (Fig. 3.5C-E), and the number of active 
zones in 1b and 1s boutons (Fig. 3.5C, F, G). Larvae fed-treated 5 mM MβCD had significantly 
fewer 1s boutons compared to controls (Fig. 3.5B, D). However, the number of 1b boutons (Fig. 
3.5B, 3.5E) and active zones (Fig. 3.5F, G) were not reduced when compared to the controls. 
Overall the effects of cholesterol extraction on the UAS-CA-PKA/+ and C155-GAL4/+ controls 
were similar to what was seen with the w1118 controls. Thus, there are no insertional effects of 
UAS-CA-PKA or C155-GAL4 on synaptic growth. Results from CA-PKA mutants shows that the 
number of type 1s boutons (Fig. 3.6C, D) and active zones (Fig. 3.6F) for 10 mM MβCD treated 
group were significantly reduced in comparison to controls. In contrast, 10 mM MβCD fed treated 
larvae showed a mild reduction, but not significant, in 1b boutons and active zones (Fig. 3.6E, G). 
Similarly, 5 mM fed treated MβCD larvae show no significant decrease in 1s and 1b boutons and 
active zones (Fig. 3.6B, D-G). However, I was unable to draw any conclusions from this 




growth, as previously suggested by Cho et al. (2015). Moreover, CA-PKA larvae seemed to display 
unhealthy behavior such as feeding problems and decreased locomotion. 
3.4 Cholesterol extraction reduces activity-dependent synaptic growth: 
The cholesterol content of membranes of mammalian hippocampal neurons has been found 
to change in response to synaptic activity (Sodero et al., 2012; Brachet et al., 2015). Brachet et 
al. (2015) provided evidence that the long-term potentiation reduced the cholesterol content in 
synaptic membranes and found a significant redistribution of cholesterol from its intracellular 
compartment in hippocampal neurons. It is unknown if increased synaptic activity affects the 
cholesterol content of membranes in Drosophila. However, Drosophila larvae raised at higher 
temperatures (30°C) have increased locomotion, which results in increased synaptic growth at the 
Drosophila larval NMJ (Sigrist et al., 2003). Furthermore, the cAMP-PKA pathway has been 
found to regulate activity-dependent synaptic growth (Zhong and Wu, 2004; Cho et al., 2015). I 
hypothesized that extracting cholesterol would inhibit the cAMP-PKA pathway and disrupt 
activity-dependent synaptic growth. Therefore, to assess whether cholesterol is required for 
activity-dependent synaptic growth, I raised larvae on normal food, 5 mM MβCD and 10 mM 
MβCD at room temperature (23°C) or a higher temperature (30°C). I then counted number of type 
1b and type 1s boutons and active zones on segment 3 of muscle fibres 6 and 7. Statistical 
comparison of larvae raised at 23°C on 10 mM MβCD showed a significant reduction in type 1s 
and 1b boutons, and 1s active zones (Fig. 3.7C, D-F) compared to controls. In contrast type 1b 
active zones of larvae fed with 10 mM MβCD (Fig. 3.7G) and type 1s and 1b boutons and active 
zones of larvae fed with 5 mM MβCD (Fig. 3.7B, D-G) showed no differences. These results were 
similar to larvae raised at 30°C on 10 mM MβCD, which showed a significant decrease in type 1s 




treated larvae also showed a significant decrease (Fig. 3.7D, F). While larvae fed with 5 mM 
MβCD showed no difference in type 1b active zones and boutons (Fig. 3.8E, G). This suggests 
that cholesterol depletion decreases activity-dependent synaptic growth seen at higher 
temperatures (30°C). In addition, consistent with previous studies (Sigrist et al., 2003; Zhong and 
Wu et al., 2004), I found that larvae raised on normal diet at 30°C showed a significant increase 
in number of type 1b boutons, 1s boutons and active zones (Fig. 3.8H) when compared to 23°C 
conditions. Results also indicated that type 1s boutons showed an increase at 5 and 10 mM MβCD 
fed treatment (Fig. 3.8H-J). In contrast, type 1s and 1b active zones and 1b boutons of larvae raised 
at 30°C on 5 mM and 10 mM MβCD showed no significant growth when compared to controls 
(23°C) (Fig. 3.8I, J). Overall, my results indicate that the numbers of 1s and 1b boutons and active 
zone were not significantly different between 23°C and 30°C in larvae fed MβCD. Since larvae on 
5 mM and 10 mM MβCD at 23°C and 30°C showed a similar decrease in growth, this may suggest 
that cholesterol inhibits activity-dependent growth through the cAMP-PKA pathway.  
3.5 Generation of UAS-D4H-GFP flies: 
To visualize the distribution of endogenous cholesterol in the cytosolic leaflet of the plasma 
membrane, I constructed a D4H (mutant construct of D4, D4D434S) vector based on domain four of 
the theta-toxin produced by Clostridium perfringens (Maekawa and Fairn, 2015). The D4H 
domain, which has a high affinity to cholesterol, has been used as a cholesterol biosensor in other 
cell types (Maekawa and Fairn, 2015). I used PCR to amplify the open reading frame of the D4H 
domain and then subcloned it into a pJFRC14-10XUAS-IVS-GFP-WPRE vector 
at EcoRI and XhoI restriction sites (Fig. 3.9A). The resulting vector was confirmed through PCR 
amplification on agarose gel (Fig. 3.9B) and with Sanger sequencing (Fig. 3.9B) to ensure 




similarity when aligned with the D4H known sequence provided by Dr. Fairn (University of 
Toronto, ON). Note that the Sanger Sequencing was unable to identify some of the bases, resulting 
in a lower alignment similarity than expected. The resulting vector was also confirmed with 
different restriction enzyme digestions (Fig 3.9 and 3.10). For this, I extracted the 10XUAS-IVS-
D4H-GFP vector from transformed Escherichia coli. I digested this vector 
with EcoRI and EcoRV (fragment sizes: 438Ibp, 2888bp, 228Ibp) and HindIII and ScaI  (fragment 
sizes: 5409bp, 2488bp, 1653bp) (Fig. 3.9A) and verified all digestions using the virtual gel 
obtained using Geneious software (Fig. 3.9B). All digestions were also consistent with the 
schematic of 10XUAS-IVS-D4H-GFP vector digestion used to identify the number of digestions 
sites (Fig. 3.9C, D). I also digested the vector with EcoRI and StuI (fragment sizes: 7374bp, 
2176bp) (Fig. 3.10A). This digestion was as expected according to the virtual gel obtained using 
Geneious software (Fig. 3.10B). This combination confirms that the 10XUAS-IVS-D4H-GFP 
sequence since StuI cuts specifically in the middle of the D4H sequence (Fig. 3.10C). Taken 






























































Figure 3.1: Cholesterol extraction with 10mM MβCD reduces synaptic growth at larvae 
NMJs:  
Representative images of fixed third instar larval (w1118) NMJs stained with an anti-HRP antibody 
(green) and anti-brp antibody (red). (A) Controls, (B) 5mM MβCD feeding-treatment and (C) 10 
mM MβCD feeding-treatment shows that the number of boutons and active zones (AZs) of type 
1b and 1s neurons were only significantly different in 10 mM MβCD treatment in comparison with 
controls. This indicates that cholesterol plays a role in synaptic growth. Note also, as shown in 
confocal images, that terminals for 10 mM MβCD (J) treatment possess fewer, albeit larger 
boutons compared to control and 5 mM MβCD (H,I). Statistical comparisons of 5mM MβCD 
feeding treatment show no significant difference in type 1s and type 1b boutons (D,E) and type 1s 
and 1b active AZs (F,G) when compared to controls. In contrast, there was a significant reduction 
in type 1b and 1s boutons (D,E) and type 1b and 1s AZs (F,G) compared to controls when larvae 
were fed 10mM MβCD. Arrowhead points to type 1b and 1s boutons. Statistical significance was 
calculated using a one-way ANOVA test (D p=0.001***; E p=0.001***; F p=0.004**;G 
p=0.049*)  with Dunnett’s multiple comparison test. Error bars indicate ±SEM. Scale bar, 20 μm 























Figure 3.2 Feeding 10mM MβCD reduces PKA fluorescence in type 1b boutons, and acute 
application reduces SPARK florescence in both type 1s and 1b boutons: Representative 
images of larvae of controls, fed-treated 5mM and fed-treated 10mM MβCD (A) stained with anti-
GFP (green). As shown in the comparison summary, there is no significant difference in 
fluorescence intensity at type 1s boutons (B) when fed treated with MβCD at 5mM and 10mM. In 
contrast, type 1b boutons (C) display a significant reduction in fluorescence intensity when fed-
treated with 10 mM MβCD. PKA-SPARK was expressed in presynaptic boutons by driving UAS-
PKA-SPARK with n-syb-GAL4. Fluorescence images of (D) controls and (E) acute application of 
MβCD for 20 min on larvae NMJs show a significant reduction in fluorescence intensity as 
indicated in comparison summary of type 1s boutons (F) and type 1b boutons (G), indicating 
significantly reduced PKA activity. All images were obtained from Drosophila abdominal 
segment 3 of muscle 6/7 NMJs of 3rd instar larvae using confocal microscopy. Arrowhead points 
to type 1b and 1s boutons. Indicated comparisons were made using the unpaired two-tail t-test and 
one-way ANOVA test (B p= 0.28; C p=0.007**) with Dunnett’s multiple comparison test. Error 










Figure 3.3 Cholesterol extraction with MβCD reduces synaptic growth in dnc1 mutants: 
Representative images of fixed third instar larval (dnc1) NMJs stained with anti-HRP antibody 
(green) and anti-brp antibody (red). (A) Controls, (B) 5mM MβCD feeding-treatment and (C) 10 
mM MβCD feeding-treatment shows that the number of boutons and active zones (AZs) of type 
1b and 1s neurons were significantly reduced in 5 and 10 mM MβCD treatment group in 
comparison to controls. Note also, as shown in confocal images, that terminals for 5 and 10 mM 
MβCD treatment possess fewer though larger boutons. Statistical comparisons of 5 and 10 mM 
MβCD feeding treatment show a significant reduction in type 1b and 1s boutons (D,E) and type 
1b and 1s AZs (F,G) when compared to controls group. Statistical significance was calculated 
using a one-way ANOVA test (D p=0.001***; E p=0.001***; F p=0.001***;G p=0.0001****)  
with Dunnett’s multiple comparison test. Error bars indicate ±SEM. Scale bar, 20 μm.  *p < 0.05, 










Figure 3.4 Cholesterol extraction with 10 mM MβCD reduces synaptic growth in UAS-CA-
PKA/+ controls:  
Representative images of (A) controls (B) 5mM MβCD feeding-treatment and (C) 10 mM MβCD 
feeding-treatment of NMJs stained with an anti-HRP antibody (green) and anti-brp antibody (red). 
Statistical comparisons of 10 mM MβCD feeding treatment show a significant reduction in type 
1b and 1s boutons (D,E) and type 1s AZs (F) compared to the controls group. In contrast, AZs of 
type 1b neurons of 10mM MβCD group (G) and type 1s and 1b AZs of 5 mM MβCD treatment 
show no difference when compared to controls. w1118 larvae were crossed with UAS-CA-PKA 
transgenic fly. All images were obtained from Drosophila abdominal segment 3 of muscle 6/7 
NMJs of 3rd instar larvae using confocal microscopy. Indicated comparisons were made using a 
one-way ANOVA test (D p=0.002**; E p=0.009**; F p=0.067; G p=0.050) with Dunnett’s 







Figure 3.5 Cholesterol extraction with 10 mM MβCD reduces synaptic growth in C155-
GAL4/+ controls: 
Representative images of larvae (A) controls (B) 5mM MβCD feeding-treatment and (C) 10 mM 
MβCD feeding-treatment of NMJs stained with an anti-HRP antibody (green) and anti-brp 
antibody (red). Statistical comparisons of 10 mM MβCD feeding treatment show a significant 
reduction in type 1b and 1s boutons (D,E), type 1s and 1b AZs (F,G) and 5 mM MβCD feeding-
treatment type 1s boutons (D) when compared to the controls. In contrast, 5 mM MβCD feeding-
treatment show no difference in type 1b boutons (E) and AZs (F,G) when compared to controls. 
w1118 flies were crossed with C155-GAL4 transgenic flies. All images were obtained from 
Drosophila abdominal segment 3 of muscle 6/7 NMJs of 3rd instar larvae using confocal 
microscopy. Indicated comparisons were made using a one-way ANOVA test (D p=0.003**; E 
p=0.0002***; F p=0.004**;G p=0.01*)  with Dunnett’s multiple comparison test. Error bars 













Figure 3.6 Cholesterol extraction with 10mM reduces the number of type 1s boutons at 
larvae NMJs in CA-PKA mutants: Representative images of fixed third instar larval NMJs 
stained with an anti-HRP antibody (green) and anti-brp antibody (red). (A) Controls, (B) 5mM 
MβCD feeding-treatment and (C) 10 mM MβCD feeding-treatment shows that the number of 
boutons and active zones (AZs) of type 1b and 1s neurons. Statistical comparisons of 10mM 
MβCD feeding treatment show a significant reduction in type 1s boutons (D) and active zones 
(AZs) (F) when compared to controls. Additionally, 10 mM MβCD fed treated larvae showed a 
mild but not significant decrease in 1b boutons (E) and AZs (G). 5 mM MβCD fed treated larvae 
show no significant different at type 1s and 1b showed boutons (D,E) and AZs (E,G). Statistical 
significance was calculated using a one-way ANOVA test (D p=0.05; E p=0.8; F p=0.02* ;G 
p=0.08)  with Dunnett’s multiple comparison test. Error bars indicate ±SEM. Scale bar, 20 μm.  














Figure 3.7 Cholesterol extraction with 10mM MβCD at room temperature (23°C) reduces 
synaptic growth at larvae NMJs: Representative images of fixed third instar larval (w1118) NMJs 
stained with an anti-HRP antibody (green) and anti-brp antibody (red). (A) Controls, (B) 5mM 
MβCD feeding-treatment and (C) 10 mM MβCD feeding-treatment shows that the number of 
boutons and active zones (AZs) of type 1b and 1s neurons. There is a significant reduction in type 
1b and 1s boutons (D,E) and type 1s AZs (F) when larvae were fed treated with 10mM MβCD. In 
contrast, statistical comparisons of 5mM MβCD feeding treatment show no significant difference 
in type 1s and type 1b boutons (D,E) and AZs (F,G) when compared to controls. Active zones in 
1b (G) in 10 mM MβCD fed treated larvae shows a mild but not significant decrease. Statistical 
significance was calculated using a one-way ANOVA test (D p=0.03*; E p=0.08; F p=0.006**;G 
p=0.22)  with Dunnett’s multiple comparison test. Error bars indicate ±SEM. Scale bar, 20 μm.  




















































Figure 3.8 Cholesterol extraction with 10mM MβCD (30°C) reduces activity-dependent 
synaptic growth, and larvae raised at 23°C and 30°C MβCD showed similar decrease in 
growth: 
 Representative images of fixed third instar larval (w1118) NMJs stained with an anti-HRP antibody 
(green) and anti-brp antibody (red). (A) Controls, (B) 5mM MβCD feeding-treatment and (C) 10 
mM MβCD feeding-treatment shows that the number of boutons and active zones (AZs) of type 
1b and 1s neurons. Statistical comparisons of 10mM MβCD feeding treatment show a significant 
reduction in type 1s and type 1b boutons (D,E) and AZs (F,G) when compared to controls. 
Additionally, 5 mM MβCD fed treated larvae show significant decrease in number of 1s boutons 
and AZs (D,F). In contrast, there is a mild but not significant decrease in type 1b boutons and AZ 
in 5 mM MβCD treatment (E,G) compared to controls. Drosophila larvae raised at higher 
temperature of 30°C results in increased synaptic growth compared to 23°C (H). 5mM and 10 mM 
MβCD fed treated larvae at 23°C and 30°C show no significant decrease in 1b boutons and active 
zones and 1s active zones (I,J). 1s active zones show a decrease in growth for 5mM and 10 mM 
MβCD fed treated at 23°C and 30°C temperature (H,I,J). Statistical significance was calculated 
using a one-way ANOVA test (D p=0.002**; E p=0.004**; F p=0.002**;G p=0.02*)  with 
Dunnett’s multiple comparison test (D-G) and unpaired two-tail t-test for (H-J). Error bars indicate 











Figure 3.9 Cloning of fourth domain (D4H) of Clostridium perfringens theta-toxin in vector: 
(A) Schematic of pJFRC14-10XUAS-IVS-D4H-GFP-WPRE vector, re-engineered to have with 
D4H domain via ligation with NotI and KpnI restriction enzymes at 7,086bp site of the vector. (B) 
PCR confirmation of the D4H domain being successfully extracted and amplified from vector. 
(Left) Representative image of D4H obtained using the virtual gel from Geneious software and 
(right) vector extracted and amplified D4H domain. The gel image is as expected according to the 
virtual gel digestion. (C) Representative image shows the D4H domain sequence, which was 
sequenced using Sanger Sequencing, displaying high similarity (green). Note, the arrows indicate 










Figure 3.10 Cloning of the fourth domain (D4H) of Clostridium perfringens theta-toxin in 
pJFRC14-10XUAS-IVS-D4H-GFP-WPRE in Escherichia coli:  
(A) The digested pJFRC14-10XUAS-IVS-D4H-GFP-WPRE vector in agarose gel analysis. The 
lanes are as follows; 1. NEB ladder, 2. EcoRI and EcoRV (3 fragments) 3. HindIII and ScaI (3 
fragments) 4. negative control of undigested plasmid. All digestions are as expected according to 
the virtual gel obtained using Geneious software (B). The lanes in the virtual gel are as follows: 1. 
NEB ladder, 2. EcoRI and EcoRV 3. HindIII and ScaI 4. negative control of undigested plasmid. 
Schematic of 10XUAS-IVS vector, re-engineered to have with D4H domain digested with 
EcoRI and EcoR, where EcoRV cuts at two different sites (C) 






















Figure 3.11 Confirming the presence of the fourth domain (D4H) in pJFRC14-10XUAS-IVS-
D4H-GFP-WPRE vector:  
(A) The digested pJFRC14-10XUAS-IVS-GFP-D4H-WPRE vector in agarose gel analysis. The 
lanes are as follows; 1. NEB ladder, 2. negative control of undigested plasmid 3. EcoRI, producing 
(1 fragments) 4. StuI  (1 fragments) 5. EcoRI and StuI combined, (2 fragments). All digestions are 
as expected according to the virtual gel obtained using Geneious software (B). The lanes in the 
virtual gel are as follows: 1. NEB ladder, 2. negative control of undigested plasmid 3. 
EcoRI 4. StuI  5. EcoRI and StuI. Schematic of pJFRC14-10XUAS-IVS-D4H-GFP-WPRE, re-
engineered to have with D4H domain, digested with EcoRI and StuI, where both cuts once at two 
different sites (C). Also note that the StuI cuts in the middle of the D4H domain, confirming its 





































From my study, four conclusions can be drawn. First, cholesterol is required for normal 
synaptic growth at Drosophila larval NMJs. Second, chronic and acute cholesterol depletion 
reduces PKA-SPARK fluorescence, suggesting that cholesterol extraction reduces PKA activity. 
Third, increasing cAMP levels could not rescue the reduced synaptic growth, which suggests that 
cholesterol may be acting downstream of the cAMP-specific phosphodiesterase. Fourth, 
cholesterol-dependent effects on the cAMP-PKA pathway may play an essential role in mediating 
activity-dependent synaptic growth. The significance of these findings are discussed below. 
Overall, my results suggest that cholesterol-dependent effects on synaptic growth may be due to 
changes in the cAMP-PKA pathway at Drosophila larval NMJs. 
4.1 Cholesterol depletion reduces synaptic growth at Drosophila larval NMJs: 
Cholesterol is a critical molecule for controlling neurite outgrowth and dendritic branching 
in cultured neurons during neuronal development and maturation. Axons and dendrites are 
differentially affected by cholesterol deficiency (Fan et al., 2002). For example, compactin, an 
inhibitor of cholesterol synthesis, inhibits dendrite outgrowth, while having little effect on axonal 
outgrowth (Fan et al., 2002). Studies conducted in vitro demonstrate that cholesterol’s effects on 
neuronal development also depend on neuronal subtype (Ko et al., 2005; Steinmetz et al., 2006; 
Funfschilling et al., 2012). Cholesterol depletion by MβCD enhances neurite outgrowth in 
hippocampal neurons and decreases neurite outgrowth in cortical neurons (Ko et al., 2012). 
Similarly, Michikawa and Yanagisawa (1999) showed that the use of compactin, a 3-hydroxy-3-
methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on neuronal cultures prepared from 
fetal rat brains, decreases neurite growth and induces neuronal death in a dose-dependent manner. 




reductase inhibitor, resulted in increased neurite length and branching (Pooler et al., 2006). 
Moreover, lines of evidence have also suggested a critical time window and dose-dependent effects 
of cholesterol on neuronal projections during development (Fan et al., 2002; Funfschilling et al., 
2012). Taken together, several studies have suggested that a decrease in neuronal cholesterol levels 
affects neurite outgrowth, with some studies finding an increase in neurite outgrowth and others 
finding a decrease in neurite outgrowth. 
In this study, I used an in vivo system to better understand the effects of cholesterol on 
nerve terminal development. I found that cholesterol depletion throughout development results in 
a decrease in the number of synaptic boutons and active zones at the Drosophila larval NMJ (Fig. 
3.1). I have found that higher concentrations (10 mM) of MβCD significantly reduced the number 
of synaptic boutons and active zones, while lower concentrations (5 mM) of MβCD had milder 
effects that were not significant (Fig 3.1D-G). Acute application (20 min) of MβCD application 
had no effect on synaptic growth (Supplemental Fig. 1). Most prior investigations were conducted 
on cultured neurons, such as a study by Jiang et al. (2010), which determined that neurons form 
longer axons and dendrites in vitro. Some of the discrepancies between previous studies and with 
my study could be due to the inability to recapitulate the in vivo environment in cultured samples 
since neurons often reside in distant environments in an intact animal, thus providing conflicting 
results depending on the growth conditions. Using pharmacological methods instead of genetic 
ones to deplete cholesterol could also explain some of these discrepancies since it is known that 
the two approaches lead to a different amount of reduction in cholesterol content. For example, 
contrast to pharmacological cholesterol removal (Fan et al., 2002; Sierra et al., 2011), genetic 
inactivation of cholesterol synthesis in SQS mutant neurons has shown a minor decrease in 




concentration of cholesterol may be needed to exhibit proper development. My results indicate 
that a proper level of cholesterol is required for type 1b and type 1s boutons and active zones 
formation. 
4.2 Cholesterol depletion affects kinase activity: 
Many neuronal functions, including synaptic development, depend on the proper regulation 
of synaptic proteins. Many of these proteins are known to be regulated by phosphorylation through 
the balancing of various protein kinase and protein phosphatase activities (Hey-Kyoung Lee, 
2010). The activity of kinases and phosphatases might be sensitive to changes in membrane 
cholesterol content (Burgos et al., 2004; Cabrera-Poch et al., 2004). In Smith et al. (2010), MβCD 
is also studied to affect neurotransmitter release, and these effects are blocked by the broad 
spectrum protein kinase-inhibitor staurosporine, thus suggesting that changes in membrane 
cholesterol content may alter protein kinase activity. Several kinases and phosphatases have been 
suggested to regulate nerve terminal growth at the Drosophila larval NMJ. For example, a protein 
phosphatase 2A (PP2A) has been known to be enriched in synaptic boutons and is required for 
normal synaptic development at the Drosophila larval NMJ (Viquez et al., 2006). The mutant well-
rounded (wrd) has a gain of function mutation in B′ regulatory subunit of PP2A and displays 
overgrowth of synaptic boutons (Viquez et al., 2006). Additionally, wrd absence has demonstrated 
to result in fewer synaptic boutons, abnormal cytoskeleton organization and defect in evoked 
transmitter release. This implicates PP2A in regulating synaptic growth and function (Viquez et 
al., 2006). Additionally, the effects of a number of kinases on nerve terminal growth have also 
been studied. Protein kinase C (PKC) is known to be widely distributed in neural tissues at NMJ, 
and substantial quantities are present during development (Lanuza et al., 2012; Lanuza et al., 




to activity-dependent synapse elimination and the maturation of NMJ during postnatal 
development (Lanuza et al., 2010; Besalduch et al., 2011). Furthermore, at Drosophila NMJs, 
atypical protein kinase C (aPKC) is also studied as being critical in NMJ development, most 
probably through actin regulation in both phosphorylation and dephosphorylation events 
(Ramachandran et al., 2009). The Drosophila foraging (for) gene encodes a cGMP-dependent 
protein kinase (PKG) and for null mutants have increased nerve terminal growth at larval NMJs 
(Dason et al., 2019). Perhaps one of the most well-studied pathways known to be directly involved 
in Drosophila NMJs involves PKA (Yoshiharia et al., 2002; Munno et al., 2003; Zhong et al., 
1992). For example, a mutation in the PKA pathway is known to decrease growth cones' motility, 
resulting in abnormal axonal branches and morphology, and distorted projections of 
mechanosensory neurons of the third instar larval NMJs (Renger et al., 2000). Similarly, a study 
by Vasin et al. (2019) showed that the growth and differentiation of new presynaptic boutons at 
the Drosophila NMJ is mediated via a PKA-dependent mechanism. The additional investigation 
also indicates that Drosophila mutants in PKA cascade influence the size of motor axon 
projections (Zhong et al., 1992). Therefore, it appears that the PKA pathway is an essential factor 
in shaping the nerve terminal development. 
In the present study, I used UAS-SPARK-PKA to visualize PKA activity (Zhang et al., 
2018) and determine if cholesterol depletion was affecting PKA activity. Interestingly, I found that 
feeding larvae 10 mM MβCD significantly reduced PKA-SPARK fluorescence in 1b boutons, thus 
indicating that PKA activity is reduced following cholesterol extraction (Fig. 3.2A, C). 
Additionally, I also found that the acute application of 10 mM MβCD shows a more substantial 
effect in 10 mM MβCD in both 1b and 1s boutons (Fig. 3.2D, G). The reason for this could be 




from the food. This could explain why acute cholesterol extraction resulted in a more substantial 
decrease than when larvae were fed MβCD throughout development. Overall, my data shows that 
cholesterol extraction reduces PKA-SPARK fluorescence, suggesting that chronic and acute 
cholesterol extraction reduces PKA activity. Zhou et al. (2012) showed an increased level of the 
activated form of PKA in rat cerebellar granule neurons in a cholesterol-containing medium. 
Furthermore, a study by Whetton, et al. (1983) provided evidence that the depletion of plasma 
membrane cholesterol inhibits adenylate cyclase activity, which is known to be an upstream 
effector of PKA. This provides evidence that cholesterol may affect PKA activity. However, these 
results are in contrast to the study by Smith et al. (2010) who inferred that cholesterol depletion 
may stimulate kinase activity at the plasma membrane. However, Smith et al. (2010) used a broad 
spectrum protein kinase inhibitor staurosporine, and it remains possible that cholesterol-dependent 
effects on neurotransmission are due to the enhanced activity of a kinase other than PKA. This 
discrepancy may also be due to other differences inherent in live imaging and fixed larvae methods 
of measuring PKA activity after cholesterol extraction and the experimental conditions. 
Additionally, it is also likely that if PKA was activated by cholesterol reduction, I could not detect 
concentrated fluorescent droplets in SPARK-based flies because of size of the boutons. Perhaps 
the use of high sensitivity and spatiotemporal resolution and magnification might allow me to 
better understand the absence or presence of fluorescent droplets upon cholesterol extraction to 
detect kinase activity. Additionally, feeding larvae PKA inhibitors such as 4-Cyano-3-
methylisoquinoline or PKA Inhibitor IV to study if that has similar effects as feeding flies MβCD 
could further strengthen the suggestion that cholesterol reduction decreases PKA activity in 





4.3 Cholesterol promotes NMJs development in a lipid raft-dependent manner: 
A possible way in which cholesterol could modulate the NMJs growth is through the role 
of the cholesterol‐rich microdomains called lipid rafts. Lipid rafts are detergent-resistant 
membrane microdomains composed of sterols, proteins and sphingolipids, that are known to be 
involved in the synaptic growth (Zhai et al., 2004, Huang et al., 2007; Huang et al., 2018). The 
assembly of lipid rafts is cholesterol-dependent (Zhai et al., 2004). Studies have found that 
cholesterol depletion by MβCD absorbs cholesterol from the membrane, thus disrupting raft 
assembly in mammalian cells and Drosophila cells (Sharma et al., 2004; Zhai et al., 2004). 
Findings by Dason et al. (2010) and Smith et al. (2010) have established that MβCD reduces the 
cholesterol content. I found that acute MβCD application did not change distribution of 
phosphatidylserine, a component of the synaptic membrane (Supplemental Fig. 2). This might 
suggest that MβCD, when applied acutely have a higher affinity to remove cholesterol without 
disturbing other components of rafts. This finding is consistent with a previous report that MβCD 
may specifically act to remove cholesterol from the membrane, thus disrupting the formation of 
membrane lipid rafts to compromise the function of raft-associated factors (Van Zanten et al., 
2006; Zhai et al., 2004; Smith et al., 2010). This also indicates that MβCD may not necessarily 
affect the levels of raft-associated factors; instead, it may compromise the localization of raft 
proteins. For example, several models have proposed that sterols, proteins and sphingolipids can 
strongly associate with lipid rafts, and rafts can aggregate these components to link particular 
proteins with distinct signaling pathways (Simons and Toomre, 2000). Together, these could 
suggest that nerve terminal growth at Drosophila NMJs may be modulated by cholesterol in lipid 
rafts and raft-localized factors involved in the growth of signaling pathways. Thus the NMJ 




Even though data have suggested that cholesterol depletion affects the activity of kinases, 
including PKA (Burgos et al., 2004; Cabrera-Poch et al., 2004; Smith et al., 2010), the 
mechanisms linking cholesterol levels to kinase activity are not fully understood. The most 
plausible mechanistic explanation for this could be that cholesterol depletion disrupts the lipid rafts 
that change the localization of components of the PKA pathway that results in decreased cAMP-
PKA signalling. In MDCK cells, MβCD treatment affects PKA activity possibly by disrupting its 
localization to lipid rafts (Burgos et al., 2004). In fact, cAMP-PKA pathway components, 
including G protein-coupled receptor (GPCRs), adenylyl cyclase, Gα proteins, phosphodiesterase 
and its effector molecules have all been indicated to associate within membrane rafts in variety of 
tissues and cell types (Willoughby and Cooper, 2007). These components have been studied to 
require distinct localizations within membrane microdomains to be functional. Since chronic and 
acute cholesterol extraction reduces PKA activity, I hypothesized that membrane rafts-cholesterol 
positively regulate cAMP-PKA pathway signaling in addition to known feedback mechanisms. 
Moreover, this regulation is highly dependent on localization within these microdomains. Thus, 
cholesterol depletion may disrupt membrane rafts (Zidovetzki and Levitan, 2007), which could 
change the localization or conformation of components of the cAMP-PKA pathway within these 
microdomains and result in reduced PKA activity. This effect is also dose-dependent as application 
of 10 mM MβCD resulted in a larger effect than 5 mM MβCD (Fig. 3.1 and Fig. 3.2). Overall, my 
results demonstrate that the activity of PKA, which regulates synaptic growth, is sensitive to 
changes in membrane cholesterol content. 
4.4 Cholesterol promotes NMJs development via the cAMP-PKA signaling pathway: 
Multiple signaling cascades mediate Drosophila NMJ development. Numerous studies 




at the Drosophila larval NMJ. cAMP is generated by GPCR-mediated activation of adenylyl 
cyclase via stimulatory proteins. cAMP then elicits highly specific cellular responses through 
PKA. Presynaptic proteins such as synapsin and complexin can then be phosphorylated by PKA 
to promote nerve terminal growth (Cho et al., 2015). To gain insights into the cellular mechanisms 
by which cholesterol regulates synaptic development, I used various mutants known to be involved 
in the cAMP-PKA pathway. Consistent with previous studies (Zhong et al., 1992), I found that 
dnc1 mutants, defective in cAMP-specific phosphodiesterase that breaks down cAMP (Byers et 
al., 1981), resulted in an increase in 1s and 1b boutons and active zones (Fig. 3.3). I tested if the 
reduced nerve terminal growth seen in larvae fed MβCD could be rescued by increasing cAMP 
levels using dnc1 mutants. Larvae raised on both 5 mM and 10 mM MβCD food showed a 
significant decrease in synaptic growth (Fig. 3.3). This could be due to dnc1 mutants having 
significantly more boutons than w1118 larvae (Fig. 3.1), hence cholesterol depletion has a much 
stronger effect on nerve terminal growth. I predicted that if cholesterol’s effects are due to reduced 
cAMP levels, then dnc1 mutants on MβCD food would not show in any reductions in synaptic 
boutons. Since my results showed that dnc1 was not able to rescue the reduced synaptic growth 
caused by feeding larvae MβCD, this implies that cholesterol’s effects on synaptic growth may not 
be due to changes in cAMP levels. Alternatively, I predicted that reduced growth in the dnc1 might 
be because cholesterol is acting downstream of cAMP and directly affecting PKA activity. Thus, 
to further explore the effect of cholesterol depletion-affected downstream pathway components, I 
used the GAL4/UAS system to express a consecutively active PKA (CA-PKA) in presynaptic 
boutons of larvae fed MβCD. First to controls for any insertional effects, my two controls, UAS-
CA-PKA/+ (Fig. 3.4) and C155-GAL4/+ (Fig. 3.5), showed similar decrease in growth to what I 




finding from CA-PKA would not because of unknown insertional effects in control larvae. Results 
from CA-PKA rescue experiments indicate that cholesterol extraction significantly reduced 1s 
boutons and active zones when larvae were fed 10 mM MβCD (Fig. 3.6C, D, F), without showing 
significant decrease when larvae were feed 5 mM MβCD. However, I was unable to draw any 
conclusions from this experiment since the CA-PKA larvae on normal food (no MβCD) did not 
show increased synaptic growth as previously revealed by Yoshihara et al. (2005) and Cho et al. 
(2015). Moreover, CA-PKA larvae seemed to display unhealthy behavior such as feeding problems 
and decreased locomotion of third instar wandering out of food. This could be because C155-
GAL4 is expressed in all neurons, thus constitutively increasing PKA activity in all neurons might 
have unexpected consequences on the behavior and development of larvae. For more conclusive 
results, this rescue experiment could be repeated with D42-GAL4 (Yoshihara et al., 2005) motor 
neuron-specific driver to study if cholesterol extraction could rescue the NMJs development in 
CA-PKA larvae.  
My findings showed that dnc1 mutants were not able to rescue the reduced synaptic growth 
seen in larvae fed MβCD. This may indicate that cholesterol acts on some other pathway 
components such as adenylate cyclase. rutabaga (rut) mutants have reduce adenylate cyclase basal 
activity (Dudai and Zvi, 1984; Livingstone et al., 1984), leading to reduced cAMP concentration 
could be studied. If cAMP levels are severely reduced, disrupting cAMP-specific 
phosphodiesterase may not bring cAMP levels back to control levels. Disruption of the rut gene is 
known to reduce synaptic growth at the larval NMJ (Tully, 1986; Dudai, 1988). Therefore, if 
cholesterol’s effects are caused by disrupting an adenylyl cyclase, rut1 mutants on MβCD food 
will not result in any further reduction in the number of synaptic boutons and active zones seen in 




Ca2+/Calmodium activation of adenylate cyclase could be also be tested (Feany, 1992). Another 
upstream component of the cAMP-PKA signaling pathway is GPCRs such as metabotropic 
glutamate receptors (mGluRs), located at presynaptic boutons. Drosophila mGluRs are associated 
with sterol-rich lipid microdomains, having a direct interaction with cholesterol (Eroglu et al., 
2002). mGluRs are known to modulate synaptic properties, including DmGluRA mutants that 
display defects in NMJ structure, such as a reduced number of synaptic boutons accompanied by 
an increase in bouton size (Bogdanik et al., 2004). Thus, further using DmGluRA larvae on MβCD 
food could help establish any link between cholesterol and mGluRs. Lastly, proteins that are 
phosphorylated by PKA and can regulate neurite outgrowth could also be studied to discover a 
link if cholesterol is acting downstream of this pathway and directly affecting these proteins’ 
activity. For example, synapsin, a protein that binds to actin and clusters synaptic vesicles, is 
known to show defects in activity-dependent synaptic growth and is phosphorylated by PKA 
(Vasin et al., 2014; Vasin et al., 2019). Phosphorylation of complexin by PKA is also known to 
regulate nerve terminal growth, consequently making it another attractive target to study (Cho et 
al., 2015). Thus, it will be interesting to further explore the role of cholesterol in the nerve terminal 
growth and whether these effects are due to proteins regulated by PKA. 
Lastly, reduced growth in dnc1 mutant could be because cholesterol is acting on a different 
pathway; thus, the extraction of cholesterol might be decreasing the number of synaptic boutons 
and active zones independent of the cAMP-PKA pathway. For example, a study by Huang et 
al. (2018) identified that mannosyl glucosylceramide (MacCer), a glycosphingolipid (GSL), 
promotes synaptic bouton formation at the Drosophila NMJs. They found that the MacCer 
positively regulates the synaptic level of wnt1/wingless (wg), whose activity depends on the 




had fewer synaptic boutons. However, feeding larvae MβCD did not reduce the levels of 
presynaptic MacCer. This may suggest that the suppression of synaptic growth by MβCD is due 
to MacCer function through the disruption of lipid rafts rather than decrease in the MacCer levels. 
This is consistent with assumption that the cholesterol extraction may disrupt the localization of 
raft-associated factors to disrupt their function without affecting their levels. Alternatively, MβCD 
may regulate synaptic growth through a pathway that does not involve MacCer. Bone morphogenic 
protein (BMP) is an essential growth-promoting signaling in NMJs in Drosophila (Bayat et al., 
2011; Van Vactor and Sigrist, 2017). Studies have also found that BMPs associate with sterol in 
the lipid rafts (North et al., 2015; Tassew et al., 2014). Thus, there is a possibility that these 
pathways could also be affected by cholesterol depletion. Although my results suggest that the 
alterations in synaptic growth that I observed were mainly caused by cholesterol acting on the 
cAMP-PKA pathway, I cannot rule out the possibility that cholesterol depletion may have caused 
reduced growth by acting on a different pathway. It is also plausible that cholesterol depletion 
simultaneously acts on the cAMP-PKA pathway and other pathways in independent but parallel 
ways to regulate the NMJs growth positively or negatively. 
To strengthen the link between cAMP-PKA and cholesterol in synaptic growth, further 
investigation could be done by measuring cAMP levels through radioimmunoassay techniques at 
Drosophila NMJs as described previously (Cheung et al., 1999). cAMP levels can also be imaged 
using ePAC1-camps or cAMPr (Hackley et al., 2018) to study the cAMP levels following 
cholesterol depletion in live imagining. This would allow us to directly determine if cAMP levels 
are reduced following cholesterol depletion. ‘FLINC’ biosensors could also be developed to 
visualize kinases' live-cell biochemical activity (Mo et al., 2017). Membrane lipid rafts have 




biochemical approaches to isolating membrane components could enable us to research lipid 
composition and protein localization (Sharma et al., 2004). Combined ePAC1-camps or cAMPr 
techniques to measure cAMP levels with pharmacological disruptors of membrane rafts such as 
CDs might provide novel insights into the alteration in localization of adenylate cyclase after 
cholesterol depletion. Thus, more sensitive and dynamic tools are needed to study cholesterol-
dependent regulation of cAMP-PKA pathway signaling dynamics in their native environment at 
NMJs. 
4.5 Cholesterol and activity-dependent synaptic growth:  
The cholesterol content of neuronal membranes is known to be regulated in response to 
neuronal activity. Specifically, membrane cholesterol levels are reduced in cultured hippocampal 
neurons following prolonged excitatory stimulation (Sodero et al., 2012). Furthermore, the 
induction of long-term potentiation in hippocampal slices results in a loss and redistribution of 
cholesterol (Brachet et al., 2015). At the Drosophila larval NMJ, growth at higher temperatures 
enhances nerve terminal growth due to enhanced locomotor activity (Sigrist et al., 2003; Zhang 
and Wu et al., 2004). The cAMP-PKA pathway is known to regulate this activity-dependent 
synaptic growth (Zhong and Wu, 2004; Cho et al., 2015). Given that my results show that 
cholesterol’s effects on nerve terminal growth may be due to changes in cAMP-PKA signaling, I 
tested whether cholesterol was required for this activity dependent synaptic growth (Fig. 3.7 and 
3.8). Consistent with previous studies (Sigrist et al., 2003; Zhong and Wu et al., 2004), I observed 
that at 30°C, there was an increase in nerve terminal growth; however, this activity-dependent 
synaptic growth was largely blocked when cholesterol was depleted using MβCD. This decrease 
in growth with 5 mM and 10 mM MβCD at 30°C was equivalent to 5 mM and 10 mM MβCD at 




in some cases suggesting the involvement of other mechanisms as previously explained by Zhong 
and Wu (1992). 
Studies on hyperexcitability mutants with defects in the K+ channels or increased Na+ 
channel expression have increased nerve terminal projections (Budnik et al., 1990). Increased 
nerve terminal growth has been observed in hyperexcitability Drosophila double mutants for K+ 
channel subunits such as ether a go-go (eag) and Shaker (Sh) (Budnik et al., 1990).  In addition, 
eag and Hyperkinetic (Hk) mutants also have increased nerve terminal due to increased excitability 
(Budnik et al., 1990). These growth effects are suppressed in the triple mutant of eag Sh nap (no 
action potential); a mutant that causes the reduction in the Na+ channel density (Wu et al., 1978; 
Ganetzky and Wu, 1986). This suggest that increased neuronal activity effects terminal 
overgrowth. Moreover, this increase in activity has been linked to cAMP levels (Renger et al., 
2000). For example, Zhong and Wu, 1992 showed that the rut-regulated cAMP pathways are an 
essential link between increased neural activity and enhanced nerve terminal growth. Additionally, 
they observed that the blocked terminal growth in rut mutant was rescued by expressing a wild-
type rut transgene at the presynaptic terminal. Together those suggest that presynaptic rut-encoded 
adenylyl cyclase activity is critical for synaptic plasticity. It should be noted that changes in 
neurotransmission and synaptic growth are not always tightly linked. For example, frequenin 
mutants that have increased neurotransmission and increased nerve terminal growth (Dason et al., 
2009). This suggests that some proteins may have differential effects on neurotransmission and 
synaptic growth.   
Increased spontaneous release is known to be required for synaptic terminal growth 
(Huntwork and Littleton 2007; Cho et al., 2015). For example, Huntwork and Littleton 2007 




miniature excitatory junctional potentials and increased number of active zones and synaptic 
overgrowth. Extending on these findings, Cho et al. (2015) showed that activity-dependent 
phosphorylation of complexin by PKA selectively enhances spontaneous release and synaptic 
growth. These studies suggest that increased spontaneous release may play a vital role in synaptic 
development.  
My data suggest that activity-dependent synaptic growth requires cholesterol and that 
cholesterol may be acting through the cAMP-PKA pathway. As mentioned above, the elevated 
cAMP levels can increase the phosphorylation of proteins such as complexin and synapsin that are 
involved in activity-dependent growth of nerve terminals (Koe et al., 2002; Cho et al., 2015). 
Hence removing cholesterol can decrease the cAMP-PKA pathways activity, thus resulting in 
reduced activity-dependent activity growth. This is supported by the fact that the numbers of 1s 
and 1b boutons and active zone were not significantly different between 23°C and 30°C after 
MβCD application (Fig.3.7 and 3.8). Similarly, activity-dependent synaptic growth is primarily 
absent in rut1 mutants (Zhong and Wu, 2004). Therefore, it is possible that cholesterol may affect 
activity-dependent synaptic growth in cAMP-PKA kinase signaling dependent manner at 
Drosophila NMJs. 
4.6 Generation of UAS-D4H-GFP flies: 
In this study, I developed a vector based on domain four (D4H) of the theta-toxin produced 
by Clostridium perfringens to serve as a genetically encoded cholesterol biosensor used in 
Drosophila. This biosensor allows to visualize cholesterol in the cytosolic leaflet of the plasma 
membrane. I was successfully able to amplify the open reading frame of the D4H domain and then 
subcloned it into a 10XUAS-IVS-GFP vector (Fig. 3.9A). Further testing confirmed through 




10XUAS-IVS-D4H-GFP vector contained the D4H sequence. This probe provides an advantage 
over other commonly used stains, such as filipin, which is easily photo-bleached and not used for 
live-cell imaging (Maekawa et al., 2015). Additionally, filipin- and fluorophore-labelled 
cholesterol can’t be distinguished from the cytosolic and exofacial leaflets of cellular membranes 
as previously described (Maekawa et al., 2015). However, the D4H probe specifically labels a 
cytosolic cholesterol leaflet and is suitable for live-cell imaging. In this regard, expressed D4H 
could prove useful for analyzing the dynamics and organization of cholesterol in presynaptic 
boutons and muscles at Drosophila larval NMJs. For example, using filipin in frog NMJs, studies 
have suggested that cholesterol is enriched at active zones, which are sites of neurotransmitter 
release, but absent from the adjacent areas that contain intramembrane particles (Ko and Propst, 
1983). Additionally, at terminals of Torpedo, sterols are distributed in patchy fashion instead of 
having a diffuse distribution (Perrelet et al., 1982). In rat cerebral cortex, the presence of sterol–
filipin complexes have also been confirmed at the presynaptic terminals and is known to change 
during the development (Surchev et al., 1995). Furthermore, synaptic vesicles have a high 
cholesterol content (Takamori et al., 2006) and this vesicular cholesterol is essential for synaptic 
vesicle endocytosis (Dason et al., 2010). Thus, this probe can be used to examine the distribution 
of cholesterol at synapses at locations such as synaptic vesicle membranes, presynaptic active 
zones, synaptic vesicles and postsynaptic membranes. Furthermore, this probe could be used to 
quantify cholesterol content levels and distribution following acute or chronic treatment with 
MβCD. In addition, localization of cholesterol at the specific locations within presynaptic 
terminals could also be determined following changes in synaptic activity. The cholesterol content 
of membranes of mammalian hippocampal neurons has been indicated to change in response to 




caveats concerning the use of the D4H probe could be that the binding efficacy of this theta-toxin 
to cholesterol may depend on the microenvironment. This limitation applies to all types of 
biosensors. Some of the cholesterol access might be limited due to membrane proteins such as ion 
channels and scaffolding proteins, which can bind to cholesterol, thus limiting freely accessible 
cholesterol (Sheng et al., 2012; Sheng et al., 2014). Previous studies demonstrate that neighboring 
phospholipids can also influence binding affinity (Flanagan et al., 2009). Cholesterol has various 
presynaptic functions, including synaptic development. However, very little information is known 
to what extent cholesterol is involved in these processes. This probe could be used to understand 
the organization of the cholesterol distribution that reside at Drosophila NMJs. 
Some of the limitations of this study might be the non-specific effects of feeding MβCD 
throughout development. As mentioned above, depletion of cholesterol is known to affect other 
pathways involved in the nerve terminal growth. For example, sphingolipids, such as 
phosphorylated sphingosines, play a crucial role in NMJ development. Studies have identified the 
upon lipid raft disruption by sterol depletion, raft-component MacCer is thought to be de-localizes 
and, in turn, restricts NMJ growth (Huang et al., 2018). However, MacCer levels were not different 
following MβCD treatment (Huang et al., 2018). Nevertheless, I can’t eliminate the possibility of 
other pathways being affected by MβCD independent and parallel of the cAMP-PKA pathway. 
Additionally, the use of MβCD is also known to affect other sterols such as ergosterol. Regardless, 
studies on MβCD is known to be the most efficient as an acceptor of cellular cholesterol when 
compared to carboxymethyl and 2-hydroxypropyl (Kilsdonk et al., 1995; Atger et al., 1997).  
The MβCD approach from this study can be coupled with complementary approaches such 
as using Drosophila mutants with impaired cholesterol trafficking. Drosophila mutants of gene 




Pick type C1 (NPC1) might provide further insight into cholesterol-dependent nerve terminal 
growth at NMJ. Also, potential live-cell, real-time imaging assay for studying membrane rafts 
could help discover the precise mechanism of the role of cholesterol in the formation of NMJs. 
This approach could also provide information on the cAMP-PKA signal transduction pathway 
within membrane microdomains to obtain an accurate understanding of what is occurring within 
the neurons. 
Synaptic development is crucial for the efficient communication between neurons and 
normal functioning of the nervous system. Cholesterol depletion is recognized as having drastic 
consequences, such as those leading to the loss of exocytotic activity and inhibition of neuronal 
growth and survival. Evidence also indicates that signal transduction, which is essential for cellular 
communication, breaks down if cholesterol levels are insufficient. Altered cholesterol composition 
of the neuronal membrane is also known to affect pathogenic mechanisms responsible for the 
neurodegeneration. To fully comprehend complex interacting pathways controlling synaptic 
development, much work needs to be done to understand the cholesterol-dependent effects on 
neuronal growth due toF changes in the cAMP-PKA pathway. My research demonstrates 
mechanisms linking perturbations of membrane cholesterol content to kinase activation, which 






























Supplemental Figure 1 Acute application of MβCD does not alter synaptic growth: 
Representative images of fixed (A) controls (w1118), (B) MβCD treated preparations (w1118) using 
confocal microscopy. As shown in the images, the acute application of MβCD for 20 min does not 
change the gross morphology of Drosophila NMJ. Mean synaptic type 1s bouton number (C) and 
type 1b bouton number (D) does not differ significantly after MβCD application. Similarly, mean 
synaptic type Is active zones (AZs) (E) and type 1b AZs (F) do not differ significantly compared 
to the controls. Larvae were co-stained the neuronal membrane marker horseradish peroxidase 
(HRP) (green) and active zone marker bruchpilot protein (brp) (red). Arrows indicate tonic-like 
type 1b (top) and phasic-like type 1s (bottom). Indicated comparisons were made using unpaired 



























Supplemental Figure 2: Acute application of MβCD does not alter lipid phosphatidylserine 
at the larval NMJ:  
(A) Controls and (B) MβCD treated images are obtained from Drosophila abdominal segment 3 
of muscle 6/7 NMJs of 3rd instar larvae. Mean fluorescence intensity of type 1s bouton (C) and 
type 1b boutons (D) shows no significant differences upon cholesterol extraction for 20 min, 
indicating that MβCD does not alter the distribution of phosphatidylserine. NMJ was GFP with 
Lactadherin C2-mCherry (LAC) (green) which binds to phosphatidylserine. Indicated 
comparisons were made using unpaired two-tail t-test. Mean ± SEM is indicated in all figures. 
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